false0001803696--12-31Q3http://fasb.org/us-gaap/2024#AccountingStandardsUpdate202206Member3個月1年1年1年1年http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#應計負債流動0001803696美元指數:重要性衡量所得之公允價值:重現性衡量成員2023-12-310001803696美元指數:績效股份成員2024-01-012024-09-300001803696us-gaap:淨銷售收入成員srt:亞洲股东US-GAAP:地理集中風險成員2023-01-012023-09-300001803696研究與開發費用成員2024-01-012024-09-300001803696us-gaap:公平價值輸入第3級成員us-gaap:USTreasuryAndGovernment成員us-gaap:公允價值計量持續性成員2024-09-300001803696us-gaap:保留盈餘成員2024-01-012024-09-300001803696us-gaap:銷售收入淨額成員adea : 其他亞洲成員us-gaap:地理集中風險成員2024-07-012024-09-300001803696us-gaap:銷售收入淨額成員us-gaap:CustomerConcentrationRiskMemberadea : 客戶A成員2024-01-012024-09-3000018036962023-12-310001803696adea : 其他亞洲成員2024-07-012024-09-300001803696adea : B類貸款設施成員2023-12-310001803696us-gaap: 銷售收入淨額成員adea : 其他亞洲成員us-gaap: 地理集中風險成員2024-01-012024-09-300001803696adea : 歐洲及中東成員2024-07-012024-09-300001803696adea : 二零二一年可轉換票據成員2024-09-300001803696us-gaap:銷售收入淨額成員us-gaap:客戶集中風險成員adea : 客戶A成員2023-01-012023-09-300001803696adea : 基於時間的獎勵成員adea : 二〇二〇年股權激勵計畫成員2024-01-012024-09-300001803696adea : 二〇二一年再融資的貸款B成員us-gaap:公允價值衡量持續成員2024-09-300001803696adea : 二〇二四年貸款B成員2024-09-300001803696us-gaap:CommonStockMember2023-01-012023-09-300001803696us-gaap:貨幣市場基金成員美元指數:公允價值輸入一級會員us-gaap:公允價值計量持續成員2023-12-310001803696us-gaap:績效股票成員關於:最低限額成員2024-01-012024-09-300001803696us-gaap:普通股成員2024-07-012024-09-3000018036962023-01-012023-09-300001803696us-gaap:受限股票單位RSU會員srt : 最低成員2023-01-012023-09-300001803696adea : 二零二零年貸款B設施成員2020-06-010001803696us-gaap:額外認股資本成員2023-01-012023-09-300001803696adea : 跨業務協議成員2022-10-010001803696adea : 客戶合同及相關關係成員文件:最大成員2024-09-300001803696us-gaap:員工股份成員2024-09-300001803696us-gaap:公允價值輸入第三級成員us-gaap:貨幣市場基金成員us-gaap:公允價值測量持續成員2024-09-300001803696adea : 假設計劃成員2024-01-012024-09-300001803696srt : 亞洲成員2023-07-012023-09-3000018036962028-01-012024-09-300001803696us-gaap:研究與開發費用成員2023-07-012023-09-300001803696srt : 最低成員2024-09-300001803696srt : 最高成員2024-01-012024-09-3000018036962022-10-010001803696us-gaap:限制性股票單位成員2023-01-012023-09-300001803696srt : 亞洲成員2024-07-012024-09-300001803696us-gaap:受限股票成員2024-09-300001803696us-gaap:員工股票成員2024-01-012024-09-300001803696adea : 其他亞洲成員2024-01-012024-09-3000018036962024-10-012024-09-300001803696us-gaap:美國國庫與政府成員2023-12-310001803696us-gaap:限制性股票成員2024-01-012024-09-300001803696adea : 設備家具及其他成員2023-12-310001803696country:加拿大2023-01-012023-09-300001803696us-gaap:基準利率成員adea : 二零二四年期限貸款B成員2024-05-202024-05-200001803696美元指數:商業本票成員us-gaap: 公允價值輸入層級1成員us-gaap: 公允價值衡量定期成員2024-09-300001803696adea : 二零二四年期限貸款B成員2023-07-012023-09-300001803696us-gaap:銷售、一般和管理費用會員2023-07-012023-09-300001803696adea : 基於時間的限制性股票獎勵成員2024-01-012024-09-300001803696us-gaap:信用集中風險成員adea : 客戶二號成員us-gaap:應收帳款成員2024-01-012024-09-300001803696美元指數:現金及現金等價物成員2023-12-3100018036962027-01-012024-09-300001803696adea : 二零二零年股權激勵計劃成員2024-01-012024-09-300001803696美元指數:公允價值輸入二級會員us-gaap:美國國債及政府成員us-gaap:公平價值測量持續成員2024-09-300001803696us-gaap:公允價值衡量經常性成員2024-09-300001803696adea : 二零二零年股權激勵計畫成員srt : 最大成員2024-05-090001803696美元指數:其他綜合收益累計項目2024-07-012024-09-300001803696us-gaap:保留盈餘成員2024-09-300001803696us-gaap:商業本票成員2023-12-310001803696adea : 二零二零年員工股票購買計畫成員2023-01-012023-09-300001803696us-gaap:銷售收入淨額成員adea : 其他亞洲成員us-gaap:地理集中風險成員2023-07-012023-09-300001803696adea : 非經常性收入成員2023-07-012023-09-300001803696adea : 非經常性收入成員2024-01-012024-09-300001803696us-gaap:貨幣市場基金成員us-gaap:公允價值測量經常性成員2024-09-300001803696us-gaap:普通股成員2023-09-300001803696us-gaap:受限制股票單位RSU成員srt : 最大成員2023-01-012023-09-300001803696us-gaap:保留盈餘成員2024-07-012024-09-300001803696us-gaap:銷售收入淨額成員us-gaap:客戶集中風險成員adea : 客戶D成員2023-07-012023-09-300001803696us-gaap:額外實收資本成員2024-09-300001803696adea : 經常性收入成員2023-01-012023-09-3000018036962022-10-012022-10-010001803696adea : 二零二四年B貸款期限成員2024-05-200001803696美國通用會計原則:企業債券會計科目us-gaap:公允價值輸入級別1成員us-gaap:公允價值計量定期成員2023-12-3100018036962024-10-250001803696us-gaap:保留盈餘成員2023-01-012023-09-300001803696us-gaap:普通股庫藏成員2022-12-310001803696us-gaap:庫藏股普通股成員2024-01-012024-09-300001803696us-gaap:庫藏股普通股成員2024-09-300001803696us-gaap:美國國債與政府成員us-gaap:公允價值計量持續成員2023-12-310001803696adea : 時間基礎的限制性股票獎勵成員2024-09-300001803696us-gaap:銷售收入淨額成員adea : 歐洲與中東成員us-gaap:地理集中風險成員2023-01-012023-09-300001803696adea : 非經常性收入成員2024-07-012024-09-300001803696country:CA2024-07-012024-09-300001803696us-gaap:庫藏股普通股成員2024-06-300001803696us-gaap:企業債務證券成員us-gaap:公允價值輸入等級2成員us-gaap:公允價值衡量持續成員2024-09-300001803696us-gaap:公允價值輸入等級2成員us-gaap:公允價值衡量持續成員2024-09-300001803696us-gaap:員工股票成員2022-04-292022-04-290001803696srt : 最低成員adea : 二零二零年股權激勵計劃成員2024-05-090001803696us-gaap:信用集中風險成員adea : 客戶一號成員us-gaap:應收帳款成員2024-01-012024-09-300001803696us-gaap:商業票據成員us-gaap:公允價值輸入級別1成員us-gaap:公允價值計量重複成員2023-12-310001803696us-gaap:商業票據成員us-gaap:公允價值計量重複成員2024-09-300001803696adea : 現有技術內容數據庫成員2024-09-3000018036962024-07-012024-09-300001803696us-gaap: 銷售收入淨額成員us-gaap: 地理集中風險成員country:美國2023-07-012023-09-300001803696us-gaap: 商業票據成員2024-09-300001803696adea : 二零二一年再融資定期貸款B成員2024-09-300001803696adea : 二零二一年再融資定期貸款B成員us-gaap: 公允價值測量循環成員2023-12-310001803696us-gaap:公平價值輸入層級3成員us-gaap:商業票據成員us-gaap:公平價值測量定期成員2023-12-310001803696us-gaap:銷售收入淨額成員adea : 客戶B成員us-gaap:客戶集中風險成員2023-07-012023-09-300001803696us-gaap:追加資本成員2023-07-012023-09-3000018036962022-10-030001803696us-gaap:公平價值測量定期成員adea : 兩千二十四年期貸款B成員2023-12-310001803696adea : 現有技術內容資料庫成員2023-12-310001803696adea : 歐洲及中東成員2024-01-012024-09-300001803696adea : 媒體平台成員2023-07-012023-09-300001803696adea : 獲得的專利核心技術成員2024-09-300001803696us-gaap: 累積其他綜合收益成員2023-12-310001803696us-gaap: 企業債務證券成員us-gaap: 公平價值輸入水平1成員us-gaap:公允價值測量持續成員2024-09-300001803696us-gaap:AvailableforsaleSecuritiesMember2024-09-300001803696us-gaap:限制性股票成員adea : 假定計劃成員2024-01-012024-09-300001803696us-gaap:公允價值輸入第二級成員us-gaap:商業票據成員us-gaap:公允價值測量持續成員2024-09-300001803696us-gaap:銷售淨收入成員adea : 其他亞洲成員us-gaap:地理集中風險成員2023-01-012023-09-300001803696us-gaap:累計其他綜合收益成員2024-09-300001803696us-gaap:公允價值輸入第3級成員us-gaap:企業債務證券成員us-gaap:公允價值衡量定期成員2023-12-310001803696adea : 營運賬戶成員2024-09-3000018036962024-06-300001803696adea : 現有技術內容數據庫成員srt : 最高成員2024-09-300001803696us-gaap:TrademarksAndTradeNamesMember2024-09-300001803696us-gaap: 累積其他綜合收益成員2024-06-300001803696us-gaap: 累積其他綜合收益成員2022-12-310001803696us-gaap: 庫藏普通股成員2024-07-012024-09-300001803696us-gaap: 保留盈餘成員2023-06-300001803696us-gaap: 普通股成員2022-12-310001803696us-gaap: 銷售收入淨額成員adea : 客戶B會員us-gaap:客戶集中風險會員2024-07-012024-09-300001803696us-gaap:績效股份會員2024-09-300001803696country:美國2023-07-012023-09-300001803696us-gaap:額外繳入資本會員2023-12-310001803696us-gaap:保留盈餘會員2024-06-300001803696adea : 2024年雙貸B會員2024-07-012024-09-300001803696us-gaap:銷售收入淨額會員country:美國US-GAAP:地理集中風險成員2024-01-012024-09-300001803696美元指數:現金及現金等價物成員2024-09-3000018036962026-01-012024-09-300001803696us-gaap:受限股票單位RSU會員2024-01-012024-09-3000018036962020-06-132024-09-300001803696us-gaap:銷售、一般和管理費用會員2023-01-012023-09-300001803696adea : 2024年期貸款B成員2024-05-202024-05-200001803696美元指數:公允價值輸入一級會員美元指數:重要性衡量所得之公允價值:重現性衡量成員2024-09-300001803696adea : 二零二一年再融資的B類定期貸款會員us-gaap:基準利率成員2024-01-012024-09-300001803696us-gaap:公平價值輸入第3級成員us-gaap: 公允價值計量反覆出現的會員2024-09-300001803696us-gaap:淨銷售收入成員us-gaap: 地理集中風險會員2024-01-012024-09-300001803696adea : 歐洲及中東會員2023-01-012023-09-300001803696us-gaap:貨幣市場基金成員us-gaap:公允價值輸入層級1成員us-gaap:公允價值測量定期成員2024-09-300001803696us-gaap:額外認股資本成員2024-01-012024-09-300001803696adea : 二零二四年貸款B成員2023-12-310001803696adea : 二零二四年貸款B成員2023-01-012023-09-300001803696美國通用會計原則:企業債券會計科目2023-12-310001803696美元指數:公允價值輸入二級會員us-gaap:貨幣市場基金成員us-gaap:公允價值衡量反覆項目2023-12-310001803696adea : 基於時間的限制性股票獎勵成員2023-12-310001803696adea : 營運帳戶成員2023-12-310001803696adea : 2021年再融資的定期貸款B成員2024-01-012024-09-300001803696美元指數:績效股份成員文件:最大成員2024-01-012024-09-300001803696adea : 歐洲及中東成員2023-07-012023-09-300001803696country:美國2024-07-012024-09-300001803696us-gaap:銷售收入淨額成員us-gaap:CustomerConcentrationRiskMemberadea : 客戶A成員2023-07-012023-09-300001803696us-gaap:額外實收資本成員2022-12-310001803696us-gaap:公允價值輸入第3級成員美元指數:商業本票成員us-gaap:公允價值測量持續成員2024-09-300001803696us-gaap:CommonStockMember2024-01-012024-09-300001803696adea : 半導體成員2024-01-012024-09-300001803696us-gaap:普通股庫藏成員2023-01-012023-09-300001803696US-GAAP:員工股票期權成員adea : 二零二零年股權激勵計劃成員2024-09-300001803696us-gaap:公司債務證券成員us-gaap:公允價值測量持續成員2024-09-300001803696美元指數:其他綜合收益累計項目2023-01-012023-09-300001803696adea : 持續收入成員2023-07-012023-09-300001803696us-gaap:公司債券證券成員us-gaap:公允價值測量持續成員2023-12-310001803696研究與開發費用成員2024-07-012024-09-300001803696us-gaap:績效股份成員2023-12-310001803696us-gaap:普通股成員2023-12-310001803696us-gaap:銷售、一般及管理費用成員2024-01-012024-09-300001803696adea : 兩千二十年股權激勵計劃成員2024-05-092024-05-090001803696us-gaap:累積其他全面收入成員2023-09-300001803696us-gaap:LeaseholdImprovementsMember2024-09-300001803696us-gaap:公允價值衡量循環成員adea : 二零二四年定期貸款B成員2024-09-300001803696us-gaap:額外實收資本成員2023-06-3000018036962029-01-012024-09-300001803696us-gaap:銷售收入淨額成員adea : 客戶B成員us-gaap:客戶集中風險成員2024-01-012024-09-300001803696adea : 半導體成員2023-01-012023-09-300001803696us-gaap:銷售收入淨額成員adea : 歐洲及中東成員us-gaap:地理集中風險成員2024-01-012024-09-300001803696us-gaap:USTreasuryAndGovernment成員us-gaap:公允價值輸入水平1成員us-gaap:公允價值衡量經常性成員2024-09-300001803696srt:亞洲股东2024-01-012024-09-300001803696adea : 設備、傢俱及其他成員2024-09-300001803696us-gaap:國庫股票普通成員2023-07-012023-09-300001803696us-gaap:公允價值輸入第3層成員us-gaap:美國國庫和政府成員us-gaap:公允價值計量定期成員2023-12-310001803696us-gaap:國庫股票普通成員2023-12-3100018036962025-01-012024-09-300001803696us-gaap:商業票據成員us-gaap:公允價值計量定期成員2023-12-310001803696us-gaap:保留盈餘成員2023-07-012023-09-300001803696us-gaap:研究及發展費用成員2023-01-012023-09-300001803696us-gaap:公允價值輸入級別3成員us-gaap:公允價值計量經常性成員2023-12-310001803696us-gaap:銷售收入淨額成員us-gaap:地理集中風險成員country:美國2024-07-012024-09-300001803696country:加拿大2024-01-012024-09-300001803696adea : B期貸款設施成員2024-09-300001803696us-gaap:銷售收入淨額成員us-gaap:地理集中風險成員country:加拿大2023-01-012023-09-300001803696country:美國2023-01-012023-09-300001803696us-gaap:保留盈餘成員2023-09-300001803696us-gaap:公允價值輸入層級3成員us-gaap:貨幣市場基金成員us-gaap:公允價值測量持續成員2023-12-310001803696adea : 半導體成員2024-07-012024-09-300001803696us-gaap: 銷售收入淨額成員us-gaap: 地理集中風險成員2023-07-012023-09-300001803696srt : 亞洲成員2023-01-012023-09-300001803696us-gaap: 累計其他綜合收益成員2023-07-012023-09-300001803696us-gaap: 銷售收入淨額成員adea : 歐洲及中東成員us-gaap: 地理集中風險成員2023-07-012023-09-300001803696us-gaap:租賃改善成員2023-12-310001803696關於:最低限額成員adea : 現有技術內容資料庫成員2024-09-300001803696adea : 非經常性收入成員2023-01-012023-09-300001803696us-gaap:累計其他綜合收益成員2023-06-300001803696us-gaap:普通股成員2024-06-300001803696adea : 2024年定期貸款B成員2024-01-012024-09-300001803696us-gaap:公司債務證券成員us-gaap:公允價值輸入層級2成員us-gaap:公允價值測量經常性成員2023-12-310001803696adea : 顧客合同及相關關係成員2023-12-310001803696us-gaap: 額外實收資本成員2024-06-300001803696us-gaap: 普通股成員2024-09-300001803696us-gaap:信用集中風險成員adea : 顧客一成員us-gaap:應收帳款成員2023-01-012023-12-310001803696us-gaap:銷售收入淨值成員us-gaap:地理集中風險成員country:加拿大2024-01-012024-09-300001803696us-gaap:貨幣市場基金成員2024-09-300001803696us-gaap:公允價值輸入等級2成員us-gaap:美國國債及政府成員us-gaap:公允價值計量定期成員2023-12-310001803696us-gaap:銷售收入淨值成員adea : 歐洲及中東成員us-gaap:地理集中風險成員2024-07-012024-09-300001803696us-gaap:銷售收入淨額成員srt : 亞洲成員us-gaap:地理集中風險成員2024-07-012024-09-300001803696adea : 兩千二十員工股票購買計劃成員2024-01-012024-09-300001803696adea : 定期收入成員2024-01-012024-09-300001803696adea : 媒體平台成員2024-07-012024-09-300001803696us-gaap:信用集中風險成員adea : 客戶二成員us-gaap:應收賬款成員2023-01-012023-12-310001803696us-gaap:銷售收入淨成員srt : 亞洲成員us-gaap:地理集中風險成員2023-07-012023-09-300001803696us-gaap:庫藏股票普通成員2023-06-300001803696adea : 媒體平台成員2024-01-012024-09-300001803696adea : 半導體成員2023-07-012023-09-300001803696us-gaap:額外支付資本成員2024-07-012024-09-300001803696srt : 最大成員adea : 獲得專利核心技術成員2024-09-3000018036962023-07-012023-09-300001803696us-gaap:銷售淨收入成員us-gaap:地理集中風險成員country:CA2024-07-012024-09-300001803696us-gaap:美國國債與政府成員us-gaap:公允價值測量定期成員2024-09-300001803696us-gaap:保留收益成員2023-12-310001803696us-gaap:銷售收入淨額成員us-gaap:地理集中風險成員2024-07-012024-09-300001803696adea: 定期收入成員2024-07-012024-09-300001803696us-gaap:銷售收入淨額成員us-gaap:地理集中風險成員country:美國2023-01-012023-09-300001803696us-gaap:公允價值輸入第3級成員us-gaap:公司債務證券成員us-gaap:公允價值測量重複成員2024-09-3000018036962024-09-300001803696us-gaap:新增繳資資本成員2023-09-300001803696us-gaap:銷售收入淨額成員us-gaap:地理集中風險成員country:CA2023-07-012023-09-300001803696adea : 兩千二十四年B期貸款成員us-gaap:擔保隔夜融資利率(SOFR)成員2024-05-202024-05-200001803696us-gaap:公允價值輸入層級2成員us-gaap:貨幣市場基金成員us-gaap:公允價值計量重複性成員2024-09-300001803696us-gaap:公允價值輸入層級1成員us-gaap:公允價值計量重複性成員2023-12-310001803696us-gaap:庫存股票普通成員2023-09-300001803696us-gaap:保留盈餘成員2022-12-310001803696us-gaap:TrademarksAndTradeNamesMember2023-12-3100018036962023-06-300001803696us-gaap:商標及商名成員srt : 最大成員2024-09-300001803696us-gaap:AvailableforsaleSecuritiesMember2023-12-310001803696adea : 媒體平台成員2023-01-012023-09-300001803696us-gaap:貨幣市場基金成員2023-12-310001803696us-gaap:普通股成員2023-06-300001803696adea : 2021年再融資期限貸款B成員adea : 歐元美元與倫敦銀行間拆借利率LIBOR成員2024-01-012024-09-300001803696us-gaap:公平價值輸入第二級成員us-gaap:商業票據成員us-gaap:公平價值計量定期成員2023-12-310001803696us-gaap:累積其他綜合收入成員2024-01-012024-09-3000018036962023-09-300001803696adea : 獲取專利核心技術成員2023-12-3100018036962021-04-220001803696adea : O 2024 Q 4 股息成員us-gaap:SubsequentEventMember2024-10-232024-10-230001803696us-gaap:受限股票成員2023-12-310001803696us-gaap:銷售收入淨額成員adea : 客戶C成員us-gaap:客戶集中風險成員2023-07-012023-09-300001803696us-gaap:銷售收入淨額成員us-gaap:客戶集中風險成員adea : 客戶A成員2024-07-012024-09-300001803696adea : 2020年二期貸款B設施成員2020-06-012020-06-010001803696美國通用會計原則:企業債券會計科目2024-09-300001803696us-gaap:TrademarksAndTradeNamesMember關於:最低限額成員2024-09-3000018036962020-06-120001803696us-gaap:淨銷售收入成員adea : 客戶B成員us-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300001803696adea : 其他亞洲成員2023-01-012023-09-300001803696us-gaap: 銷售收入淨額成員srt:亞洲股东US-GAAP:地理集中風險成員2024-01-012024-09-300001803696其他亞洲成員2023-07-012023-09-300001803696文件:最大成員2024-09-300001803696country:加拿大2023-07-012023-09-300001803696us-gaap:USTreasuryAndGovernment成員2024-09-300001803696country:美國2024-01-012024-09-300001803696銷售收入淨額成員us-gaap:地理集中風險成員2023-01-012023-09-3000018036962022-12-310001803696us-gaap:美國國庫券和政府成員美元指數:公允價值輸入一級會員美元指數:重要性衡量所得之公允價值:重現性衡量成員2023-12-310001803696us-gaap:貨幣市場基金成員us-gaap:公允價值計量持續成員2023-12-310001803696us-gaap:CommonStockMember2023-07-012023-09-300001803696adea : 客戶合同及相關關係成員srt : 最小成員2024-09-300001803696adea : 2021年再融資的B類定期貸款成員2023-12-310001803696美元指數:公允價值輸入二級會員us-gaap: 公允價值計量持續成員2023-12-310001803696srt : 最小成員adea : 獲得的專利核心技術成員2024-09-3000018036962024-01-012024-09-300001803696adea : 客戶合同及相關關係成員2024-09-300001803696us-gaap:銷售、一般和管理費用會員2024-07-012024-09-30adea:NumberOfShareiso4217:美元指數xbrli:股份純種成員adea:Segmentxbrli:sharesadea:RevenueModeladea:Patentiso4217:美元指數adea:客戶

 

美國

證券交易委員會

華盛頓特區 20549

 

表單 10-Q

 

(標記一個)

根據1934年證券交易法第13或15(d)條款提交的季度報告

截至季度期 9月30日 2024

根據1934年證券交易法第13條或第15(d)條的過渡報告

委員會檔案編號: 001-39304

 

ADEIA INC.

(註冊人的準確名稱,如其章程所指定)

 

 

特拉華州

 

84-4734590

(註冊或組織的)提起訴訟的州或其他司法管轄區(如適用)

公司註冊或組建)

 

(美國國稅局僱主

識別號)

 

 

3025 果園公園大道, 聖荷西, 加利福尼亞

 

95134

(主要執行辦公室地址)

 

(Zip Code)

(408) 473-2500

(註冊人的電話號碼,包括區號)

 

 

根據法案第12(b)節註冊的證券:

 

每個類別的標題

交易

標的(們)

註冊的每個交易所的名稱

普通股(面值每股0.001美元)

ADEA

納斯達克全球精選市場

 

請通過勾選標記指明註冊人是否(1)在過去12個月內(或註冊人被要求提交此類報告的較短期間內)根據1934年證券交易法第13或15(d)條提交了所有要求提交的報告,以及(2)在過去90天內是否受到此類提交要求的約束。 ☒ 否 ☐

請使用勾選標記指示註冊者在過去12個月內(或註冊者被要求提交此類文件的更短時間內)是否電子提交了根據規則405和證券交易委員會規則S-t (§ 232.405)所要求的每個互動數據文件。 ☒ 否 ☐

請勾選註冊者是大型加速文件提交者、加速文件提交者、非加速文件提交者、小型報告公司還是新興增長公司。請參見《證交易法》規則120億.2 中「大型加速文件提交者」、「加速文件提交者」、「小型報告公司」和「新興增長公司」的定義。

 

大型加速報告人

 

加速報告人

非加速報告人

 

小型報告公司

新興成長公司

 

 

 

 

如果是新興成長型公司,在選中複選標記的同時,如果公司已選擇不使用根據證券交易法第13(a)條提供的任何新的或修訂後的財務會計準則的延長過渡期來符合新的或修訂後的財務會計準則,則表明該公司已選擇不使用根據證券交易法第13(a)條提供的任何新的或修訂後的財務會計準則的延長過渡期來符合新的或修訂後的財務會計準則。☐

請在勾選符號上註明本公司是否爲外殼公司(在證券交易法12b-2規定中定義)。是 ☐ 否

截至2024年10月25日,註冊人的普通股流通股份數量 百萬,註冊人 109,264,937

 

 


 

ADEIA INC.

FORM 10-Q

截至2024年9月30日的季度期間

目錄

 

 

 

 

 

第一部分

 

 

項目1.

基本報表(未經審計)

 

3

 

簡明合併收益表 – 截至2024年與2023年9月30日的三個月和九個月

 

3

 

簡明合併全面收益表 – 截至2024年與2023年9月30日的三個月和九個月

 

4

 

簡明合併資產負債表 – 截至2024年9月30日和2023年12月31日

 

5

 

簡明合併現金流量表 – 截至2024年與2023年9月30日的九個月

 

6

 

合併簡明權益報表 -截至2024年和2023年 三個月和九個月 九月30日

 

7

 

附註至簡明合併財務報表

 

9

項目2.

管理層對控件和經營結果的討論與分析

 

33

項目3。

關於市場風險的定量和定性披露

 

43

項目4。

控制和程序

 

43

 

 

 

 

 

第二部分

 

 

項目1.

法律訴訟

 

44

項目1A。

Risk Factors

 

46

項目2.

未註冊的股票證券銷售及收益使用

 

46

項目3。

高級證券的缺省

 

46

項目4。

礦業安全披露

 

46

第五項。

其他信息

 

46

第六項。

展覽品

 

47

 

 

 

 

簽名

 

 

48

 

2


 

第一部分 – 財務信息

項目1. 財務報表

ADEIA INC.

綜合財務報表收入報表

(以千爲單位,除每股金額外)

(未經審計)

 

 

 

截至三個月

 

截至九個月

 

 

九月三十日
2024

 

九月三十日
2023

 

九月三十日
2024

 

九月三十日
2023

營業收入

 

$86,101

 

$101,397

 

$256,856

 

$301,921

營業費用:

 

 

 

 

 

 

 

 

研究和開發

 

14,825

 

13,768

 

43,549

 

39,895

銷售、一般和行政

 

26,903

 

21,921

 

75,549

 

71,177

攤銷費用

 

13,600

 

23,386

 

56,787

 

70,725

訴訟費用

 

2,652

 

2,205

 

9,844

 

7,161

總營業費用

 

57,980

 

61,280

 

185,729

 

188,958

營業收入

 

28,121

 

40,117

 

71,127

 

112,963

利息支出

 

(12,758)

 

(15,659)

 

(40,229)

 

(47,137)

其他收入和費用,淨額

 

1,431

 

1,486

 

4,259

 

4,723

債務清償損失

 

 

 

(453)

 

稅前收入

 

16,794

 

25,944

 

34,704

 

70,549

所得稅準備(收益)

 

(2,520)

 

1,712

 

6,109

 

15,877

淨利潤

 

$19,314

 

$24,232

 

$28,595

 

$54,672

每股淨利潤:

 

 

 

 

 

 

 

 

基本

 

$0.18

 

$0.23

 

$0.26

 

$0.51

稀釋

 

$0.17

 

$0.21

 

$0.25

 

$0.48

用於每股計算的加權平均股份數

 

 

 

 

 

 

 

 

基本

 

109,035

 

106,902

 

108,491

 

106,322

稀釋

 

113,124

 

112,929

 

112,881

 

112,765

 

附帶的說明是這些未經審計的簡明合併基本報表的一個不可或缺的部分。

3


 

ADEIA INC.

綜合收益的濃縮合並財務報表綜合收益

(以千爲單位)

(未經審計)

 

 

 

截至三個月

 

 

截至九個月

 

 

 

九月三十日
2024

 

 

九月三十日
2023

 

 

九月三十日
2024

 

 

九月三十日
2023

 

淨利潤

 

$

19,314

 

 

$

24,232

 

 

$

28,595

 

 

$

54,672

 

其他綜合收益(損失), 淨額(稅後):

 

 

 

 

 

 

 

 

 

 

 

 

外幣翻譯調整的變動

 

 

 

 

 

 

 

 

 

 

 

9

 

可供出售債務證券的未實現收益(虧損)

 

 

247

 

 

 

12

 

 

 

159

 

 

 

(27

)

其他綜合收入(損失),扣除稅後

 

 

247

 

 

 

12

 

 

 

159

 

 

 

(18

)

綜合收益總額

 

$

19,561

 

 

$

24,244

 

 

$

28,754

 

 

$

54,654

 

 

附帶的說明是這些未經審計的簡明合併基本報表的一個不可或缺的部分。

4


 

ADEIA INC.

C壓縮合並資產負債表

(單位:千,除了面值以外)

(未經審計)

 

 

 

九月三十日
2024

 

 

12月31日
2023

 

資產

 

 

 

 

 

 

流動資產:

 

 

 

 

 

 

現金及現金等價物

 

$

60,698

 

 

$

54,560

 

可售證券

 

 

28,486

 

 

 

29,012

 

應收賬款,扣除信用損失準備金$713 和 $1,463, 分別

 

 

43,948

 

 

 

39,651

 

未開票合同應收賬款,淨額

 

 

101,593

 

 

 

74,919

 

其他流動資產

 

 

9,985

 

 

 

7,700

 

總流動資產

 

 

244,710

 

 

 

205,842

 

長期未開票合同應收賬款

 

 

62,880

 

 

 

73,843

 

物業及設備(淨額)

 

 

6,473

 

 

 

6,971

 

經營租賃使用權資產

 

 

8,817

 

 

 

9,484

 

無形資產,淨值

 

 

297,361

 

 

 

347,172

 

商譽

 

 

313,660

 

 

 

313,660

 

長期所得稅應收款

 

 

120,391

 

 

 

120,338

 

其他長期資產

 

 

28,873

 

 

 

28,246

 

總資產

 

$

1,083,165

 

 

$

1,105,556

 

負債和權益

 

 

 

 

 

 

流動負債:

 

 

 

 

 

 

應付賬款

 

$

7,717

 

 

$

9,623

 

應計法律費用

 

 

2,236

 

 

 

1,796

 

應計負債

 

 

16,237

 

 

 

17,342

 

長期債務的流動部分

 

 

24,732

 

 

 

66,145

 

遞延收入

 

 

20,576

 

 

 

7,132

 

總流動負債

 

 

71,498

 

 

 

102,038

 

遞延營業收入,減去流動部分

 

 

24,474

 

 

 

17,672

 

長期負債,淨額

 

 

499,692

 

 

 

519,550

 

非流動經營租賃負債

 

 

9,180

 

 

 

9,730

 

長期應交所得稅

 

 

82,422

 

 

 

81,834

 

其他長期負債

 

 

17,684

 

 

 

18,110

 

總負債

 

 

704,950

 

 

 

748,934

 

承諾和或有事項(註釋14)

 

 

 

 

 

 

股東權益:

 

 

 

 

 

 

優先股: $0.001 面值;(2024年:授權 15,000 股數;2023年:授權 15,000股數和  發行的和流通的股份)

 

 

 

 

 

普通股:$0.001 面值; (2024年: 授權的 350,000 股份,發行 123,538 股份,流通 109,193 股份; 2023年: 授權的 350,000 股份,發行 120,730 股票,流通中的 107,384 股票)

 

 

124

 

 

 

121

 

額外實收資本

 

 

639,727

 

 

 

635,331

 

按成本計算的庫藏股 (2024: 14,345 股票; 2023: 13,346 股票)

 

 

(234,057

)

 

 

(222,497

)

累計其他綜合損失

 

 

151

 

 

 

(8

)

累計虧損

 

 

(27,730

)

 

 

(56,325

)

股東權益總額

 

 

378,215

 

 

 

356,622

 

總負債及權益

 

$

1,083,165

 

 

$

1,105,556

 

 

附帶的說明是這些未經審計的簡明合併基本報表的一個不可或缺的部分。

5


 

ADEIA INC.

綜合現金流量表 現金流量

(以千爲單位)

(未經審計)

 

 

 

截至九個月

 

 

 

2024年9月30日

 

 

2023年9月30日

 

經營活動產生的現金流:

 

 

 

 

 

 

淨利潤

 

$

28,595

 

 

$

54,672

 

調整淨利潤與經營活動產生的現金淨額之間的差異:

 

 

 

 

 

 

折舊

 

 

1,536

 

 

 

1,151

 

無形資產攤銷

 

 

56,787

 

 

 

70,725

 

基於股票的補償費用

 

 

19,156

 

 

 

13,070

 

遞延所得稅

 

 

(1,818

)

 

 

2

 

債務清償損失

 

 

453

 

 

 

 

債務發行成本的攤銷

 

 

2,429

 

 

 

3,251

 

其他

 

 

(1,421

)

 

 

107

 

經營資產和負債的變動:

 

 

 

 

 

 

應收賬款

 

 

(3,547

)

 

 

13,728

 

未開票合同應收款

 

 

(15,711

)

 

 

(34,415

)

其他資產

 

 

(481

)

 

 

9,993

 

應付賬款

 

 

(170

)

 

 

265

 

應計及其他負債

 

 

(1,053

)

 

 

(14,515

)

遞延收入

 

 

20,246

 

 

 

(4,719

)

淨現金來自於經營活動

 

 

105,001

 

 

 

113,315

 

投資活動的現金流:

 

 

 

 

 

 

購買房產和設備

 

 

(1,274

)

 

 

(1,936

)

無形資產購置

 

 

(8,476

)

 

 

(95

)

購買期權

 

 

(25,094

)

 

 

(33,598

)

來自投資到期的收益

 

 

26,450

 

 

 

3,800

 

投資活動產生的淨現金

 

 

(8,394

)

 

 

(31,829

)

融資活動產生的現金流:

 

 

 

 

 

 

分紅派息

 

 

(16,303

)

 

 

(15,979

)

償還債務

 

 

(64,153

)

 

 

(118,875

)

來自員工股票購買計劃和行使期權的收益

 

 

1,547

 

 

 

1,172

 

因股權獎勵的稅款扣繳而回購普通股

 

 

(11,560

)

 

 

(10,504

)

融資活動的淨現金

 

 

(90,469

)

 

 

(144,186

)

現金及現金等價物的淨增加(減少)

 

 

6,138

 

 

 

(62,700

)

期初的現金及現金等價物

 

 

54,560

 

 

 

114,555

 

期末現金及現金等價物

 

$

60,698

 

 

$

51,855

 

現金流信息的補充披露:

 

 

 

 

 

 

支付的利息

 

$

36,221

 

 

$

43,507

 

所得稅支付,扣除退款後的淨額

 

$

7,694

 

 

$

3,431

 

期末未支付的物業及設備採購

 

$

235

 

 

$

425

 

 

 

附帶的說明是這些未經審計的簡明合併基本報表的一個不可或缺的部分。

6


 

ADEIA INC.

簡化合並 權益報表

(以千爲單位,除每股金額外)

(未經審計)

截至2024年9月30日的三個月

 

普通股

 

 

額外
實收資本

 

 

庫存股

 

 

累計
其他綜合收益(損失)

 

 

累積
赤字

 

 

總計
股東權益

 

 

 

股份

 

 

金額

 

 

 

 

 

股份

 

 

金額

 

 

 

 

 

 

 

 

 

 

截至2024年7月1日的餘額

 

 

108,854

 

 

$

123

 

 

$

637,752

 

 

 

14,138

 

 

$

(231,599

)

 

$

(96

)

 

$

(47,044

)

 

$

359,136

 

淨利潤

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19,314

 

 

 

19,314

 

其他綜合收益

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

247

 

 

 

 

 

 

247

 

普通股的現金分紅($0.05 每股)

 

 

 

 

 

 

 

 

(5,450

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(5,450

)

與行使期權相關的普通股發行

 

 

1

 

 

 

 

 

 

6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6

 

與員工股票購買計劃相關的普通股發行

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

限制性股票的發行,淨額爲取消的股票

 

 

545

 

 

 

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

與限制性獎勵的淨股票結算相關的扣稅

 

 

(207

)

 

 

 

 

 

 

 

 

207

 

 

 

(2,458

)

 

 

 

 

 

 

 

 

(2,458

)

基於股票的補償費用

 

 

 

 

 

 

 

 

7,419

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,419

 

截至2024年9月30日的餘額

 

 

109,193

 

 

$

124

 

 

$

639,727

 

 

 

14,345

 

 

$

(234,057

)

 

$

151

 

 

$

(27,730

)

 

$

378,215

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

截至2024年9月的九個月

 

普通股

 

 

額外
實收資本

 

 

庫存股

 

 

累計
其他綜合收益(損失)

 

 

累積
赤字

 

 

總計
股東權益

 

 

 

股份

 

 

金額

 

 

 

 

 

股份

 

 

金額

 

 

 

 

 

 

 

 

 

 

2024年1月1日的餘額

 

 

107,384

 

 

$

121

 

 

$

635,331

 

 

 

13,346

 

 

$

(222,497

)

 

$

(8

)

 

$

(56,325

)

 

$

356,622

 

淨利潤

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

28,595

 

 

 

28,595

 

其他綜合收益

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

159

 

 

 

 

 

 

159

 

普通股的現金分紅派息($0.15 每股)

 

 

 

 

 

 

 

 

(16,303

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(16,303

)

因行使期權而發行普通股

 

 

54

 

 

 

 

 

 

568

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

568

 

因員工股票購買計劃而發行普通股

 

 

120

 

 

 

 

 

 

975

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

975

 

限制性股票的發行,扣除已取消的股票

 

 

2,634

 

 

 

4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4

 

與限制性獎勵淨股票結算相關的預扣稅

 

 

(999

)

 

 

(1

)

 

 

 

 

 

999

 

 

 

(11,560

)

 

 

 

 

 

 

 

 

(11,561

)

基於股票的補償費用

 

 

 

 

 

 

 

 

19,156

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19,156

 

截至2024年9月30日的餘額

 

 

109,193

 

 

$

124

 

 

$

639,727

 

 

 

14,345

 

 

$

(234,057

)

 

$

151

 

 

$

(27,730

)

 

$

378,215

 

附帶的說明是這些未經審計的簡明合併基本報表的一個不可或缺的部分。

7


 

ADEIA INC.

濃縮合並權益報表

(以千爲單位,除每股金額外)

(未經審計)

 

 

 

公司股東權益總計

 

 

 

 

 

 

 

普通股

 

 

額外
實收資本

 

 

庫存股

 

 

累計
其他
綜合收益(損失)

 

 

累積
赤字

 

 

 

總計
股東權益

 

截至2023年9月30日的三個月

 

股份

 

 

金額

 

 

 

 

 

股份

 

 

金額

 

 

 

 

 

 

 

 

 

 

 

截至2023年7月1日的餘額

 

 

106,606

 

 

$

119

 

 

$

634,954

 

 

 

12,989

 

 

$

(218,714

)

 

$

(81

)

 

$

(93,257

)

 

 

$

323,021

 

淨利潤

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

24,232

 

 

 

 

24,232

 

其他綜合收益

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12

 

 

 

 

 

 

 

12

 

支付普通股的現金分紅($0.05每股)

 

 

 

 

 

 

 

 

(5,343

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(5,343

)

與行使期權有關的普通股發行

 

 

4

 

 

 

 

 

 

41

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

41

 

限制性股票的發行,淨額爲已取消股份

 

 

760

 

 

 

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

與限制性獎勵的淨股份結算相關的預扣稅

 

 

(274

)

 

 

 

 

 

 

 

 

274

 

 

 

(3,013

)

 

 

 

 

 

 

 

 

 

(3,013

)

基於股票的補償費用

 

 

 

 

 

 

 

 

4,874

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,874

 

截至2023年9月30日的餘額

 

 

107,096

 

 

$

120

 

 

$

634,526

 

 

 

13,263

 

 

$

(221,727

)

 

$

(69

)

 

$

(69,025

)

 

 

$

343,825

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

公司股東權益總額

 

 

 

 

 

 

 

普通股

 

 

額外
實收資本

 

 

庫存股

 

 

累計
其他
綜合虧損

 

 

累積
赤字

 

 

 

總計
股東權益

 

截至2023年9月30日的九個月

 

股份

 

 

金額

 

 

 

 

 

股份

 

 

金額

 

 

 

 

 

 

 

 

 

 

 

2023年1月1日餘額

 

 

105,167

 

 

$

117

 

 

$

636,266

 

 

 

12,225

 

 

$

(211,223

)

 

$

(51

)

 

$

(123,697

)

 

 

$

301,412

 

淨利潤

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

54,672

 

 

 

 

54,672

 

其他綜合損失

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(18

)

 

 

 

 

 

 

(18

)

普通股的現金分紅派息($0.15每股)

 

 

 

 

 

 

 

 

(15,979

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(15,979

)

根據期權行使的普通股發行

 

 

42

 

 

 

 

 

 

450

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

450

 

根據員工股票購買計劃的普通股發行

 

 

87

 

 

 

 

 

 

719

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

719

 

限制性股票的發行,扣除已註銷的股票

 

 

2,838

 

 

 

3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3

 

與限制性獎勵的淨股票結算相關的預扣稅

 

 

(1,038

)

 

 

 

 

 

 

 

 

1,038

 

 

 

(10,504

)

 

 

 

 

 

 

 

 

 

(10,504

)

基於股票的補償費用

 

 

 

 

 

 

 

 

13,070

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

13,070

 

截至2023年9月30日的餘額

 

 

107,096

 

 

$

120

 

 

$

634,526

 

 

 

13,263

 

 

$

(221,727

)

 

$

(69

)

 

$

(69,025

)

 

 

$

343,825

 

 

附帶的說明是這些未經審計的簡明合併基本報表的一個不可或缺的部分。

8


 

ADEIA INC.

附註 C壓縮合並基本報表

(未經審計)

註釋 1 – 公司及報告基礎

Adeia Inc.(「公司」)是一家特拉華州公司,是行業內最大的知識產權(「IP」)授權平台之一,擁有多樣化的媒體和半導體IP組合,包含超過 11,750 項專利和專利申請,遍佈全球。

在2022年10月1日,公司完成了之前宣佈的產品業務分拆(「分拆」),將其業務分爲一家獨立的上市公司,Xperi Inc.(「Xperi Inc.」)。本次分拆是通過公司向截至2022年9月21日(「記錄日期」)收盤時持有公司普通股的股東分配 100 百分之 的Xperi Inc.普通股的流通股。每位公司記錄股東獲得 四個 股Xperi Inc.的普通股,作爲每 公司在記錄日期持有的普通股股份。分離後,公司不再持有Xperi Inc.的任何所有權,Xperi Inc.現在在紐約證券交易所以標的「XPER」上市。自2022年10月3日營業開始時,公司普通股每股面值$0.001 開始在納斯達克全球精選市場以新的標的「ADEA」交易。

此外,由於分離,公司在2022年第四季度改變了其經營結構,導致 一個 可報告的行業板塊,IP授權-半導體。

附帶的未經審計的簡明合併基本報表是公司根據美國公認會計原則(「GAAP」)以及證券交易委員會(「SEC」)關於臨時財務信息的適用規則和規定編制的。截至2023年12月31日的金額來源於公司年度審計的合併基本報表,這些報告包含在截止至2023年12月31日的年度報告Form 10-K中,並於2024年2月23日提交(「Form 10-K」)。這些簡明合併基本報表應與截至2023年12月31日的年度審計合併基本報表及其附註一起閱讀。

某些信息和腳註披露通常包括在根據美國GAAP編制的財務報表中,已根據這些規則和規定進行了簡化或省略。在管理層看來,附帶的未經審計的簡明合併基本報表反映了必要的所有調整(包括正常的經常性調整),公正地陳述了公司截至所示期間的財務狀況及其經營成果和現金流。截至2024年9月30日的三個月和九個月的經營結果不一定表明截至2024年12月31日的完整年度或任何未來期間可能預期的結果,公司對此不作任何表述。

註釋 2 – 重要會計政策摘要

截至2024年9月30日的三個月和九個月期間,公司的重要會計政策沒有重大變化,這與在10-K表格中描述的重要會計政策相比。

9


 

估計的使用

根據美國通用會計準則(U.S. GAAP)編制基本報表要求管理層做出估計和假設,這會影響基本報表及附註中報告的金額。需要管理層做出最重要、最具挑戰性和主觀判斷的會計估計和假設包括識別合同中的履約義務、估計變量對價、在收到許可方的特許權使用費報告之前估計季度特許權使用費、確定單獨銷售價格,以及在多個履約義務的合同中分配對價、評估商譽的可回收性、評估其他無形資產和長期資產的使用壽命及可回收性、確認和計量當前及遞延所得稅資產和負債、評估未確認的稅收利益以及因業務組合產生的購買會計等。公司實際經歷的結果可能與管理層的估計有所不同。這些估計可能會隨着新事件的發生和額外信息的獲得而發生變化,並在合併基本報表中一旦知曉就被確認。

近期採用的會計準則

在2020年3月,FASB發佈了ASU 2020-04,利率改革(第848主題):便利利率改革對財務報告的影響(「ASU 2020-04」)。ASU 2020-04爲將美國通用會計準則應用於合同、對沖關係和其他受利率改革影響的交易提供了可選的簡化措施和例外情況,前提是符合某些標準。ASU 2020-04中的修訂僅適用於引用倫敦銀行間拆借利率(「LIBOR」)或因利率改革預計將被停止的其他參考利率的合同、對沖關係和其他交易。在2022年12月,FASB發佈了ASU 2022-06,利率改革(第848主題):第848主題的期限延遲(“ASU 2022-06),其中推遲了主題848的應用日期至2024年12月31日。在 2023年第二季度,公司 未採取 主題848並修改了其債務協議以參考其他利率。 adoption did 對公司的縮減合併基本報表沒有產生重大影響。

尚未採用的最近發佈的會計公告

在2023年11月,FASB發佈了ASU 2023-07,分部報告(主題280):可報告分部披露的改進(「ASU 2023-07」),要求公共實體在中期和年度基礎上披露其可報告分部的重要費用和其他分部項目的信息。單一可報告分部的公共實體需要在中期和年度基礎上應用ASU 2023-07的披露要求,並遵守ASC 280中現有的所有分部披露和調節要求。ASU 2023-07自2023年12月15日後開始的財政年度生效,並且在2024年12月15日後開始的財政年度內的中期也適用,允許提前採用。公司目前正在評估採用ASU 2023-07的影響。

在2023年12月,FASB發佈了ASU 2023-09,所得稅(主題740):所得稅披露的改進(「ASU 2023-09」),要求公共實體在年度基礎上披露稅率調節中的具體類別,以及按管轄區列示的所支付的所得稅。ASU 2023-09自2024年12月15日後開始的財政年度生效,允許提前採用。公司目前正在評估採用ASU 2023-09的影響。

10


 

註釋3 – 營業收入

收入確認

一般情況

當知識產權("IP")的控制權轉移給客戶時,收入確認的金額反映了公司預計在許可公司IP時應得的對價,其中可能包括一般可以區分並作爲單獨履約義務覈算的各種IP權利和服務的組合。在外國扣繳稅被公司的被許可方扣留的情況下,收入確認時不扣除直接由被許可方向當地稅務機關支付的扣繳稅。

公司的某些合同與客戶的合同包含多項履約義務。對於這些合同,若單項履約義務是獨立的,則單獨進行覈算。在包含多項履約義務的合同中,交易價格按相對單獨銷售價格的基礎分配給各個履約義務。單獨銷售價格的確定考慮市場條件、合同的規模和範圍、客戶和地理信息以及其他因素。當可觀察的價格不可用時,單獨履約義務的單獨銷售價格基於調整後的市場評估方法,以估計客戶在相關市場願意爲許可公司IP權利支付的價格。在合同中履約義務之間的交易價格分配可能影響在特定期間確認的營業收入的金額和時間。

當與客戶的合同包含變量對價時,會在合同開始時以及每個後續報告期內對公司預計應得的轉讓承諾的IP權利或服務的對價進行估計,直到與變量對價相關的不確定性得以解決。通過考慮所有可用信息(歷史、當前和預測)來估計變量對價,並在可以獲得額外信息時進行更新。變量對價的估計包括在交易價格中,前提是在與變量對價相關的不確定性得以解決時,不顯著逆轉累計確認的營業收入是很可能的。當與變量對價相關的不確定性涉及由於法律合同爭議而導致的潛在價格調整時,公司會根據情況選擇最適當的預期值法或最可能金額法來估計變量對價,並考慮所有可用信息,包括歷史數據和經驗。估計與潛在未來價格調整相關的變量對價需要在評估可能的結果時做出重大判斷。因變量對價估計的變動所導致的後續交易價格變動會按照合同成立時的相同基礎分配給合同中的履約義務。

當變動對價以基於銷售或使用的特許權使用費的形式交換IP許可時,營業收入在後續銷售或使用發生時或與已分配部分或全部基於銷售或使用的特許權使用費的履行義務已滿足或部分滿足時確認。

營業收入產生活動的描述

IP授權安排

公司將(i)其媒體專利組合(「媒體IP授權」)授權給多個頻道的視頻節目分發商、超高清視頻服務提供商、消費電子製造商、社交媒體和其他新媒體公司,以及(ii)其半導體技術及相關專利組合(「半導體IP授權」)授權給存儲器、邏輯、傳感器、射頻組件和代工公司。公司通常根據以下模型授權其IP組合: (i) 按單元或按用戶的媒體IP或半導體IP特許權使用費授權,(ii) 固定費用媒體IP授權,以及(iii) 固定費用或最低保證的半導體IP授權。

11


 

 

按單位或按訂閱用戶數計費的媒體IP或半導體IP特許權授權

公司在許可方的銷售或生產估計發生期確認按單位或按訂閱用戶數計費的IP特許權授權的營業收入,當許可方隨後報告實際銷售或生產時,會對營業收入進行調整,這通常是在使用或運輸後的一個月或一個季度。估計客戶的每月或每季度的特許權使用費在收到特許權報告之前,需要公司對預測趨勢和增長率做出重大假設和判斷,這將對公司每季度報告的營業收入產生實質性影響。

固定費用媒體IP特許權授權

公司的長期固定費用媒體IP特許權授權合同爲客戶提供在合同期間內對未來專利技術的權利,這些權利與合同開始時提供的專利技術高度相互依賴或高度相關。公司將這些權利視爲一個單一的履約義務,營業收入在固定費用特許權授權合同的期限內按直線法確認。交易價格已考慮任何重大融資成分的影響,這些成分是使用借款人特定的、風險調整的利率計算的,相關的利息收入或費用是在有效利率基礎上逐漸確認的。

固定費用或最低保障半導體IP特許權授權

公司進入固定費用或最低保障的半導體IP特許權授權合同,許可方支付固定費用以在許可期限內將公司的IP技術納入許可方的產品。在最低保障合同中,固定費用部分對應於客戶必須生產或支付的最低單位或金額,對於超出最低的任何單位或金額,收取額外的按單位計費費用。公司通常在許可期限開始時確認全額固定費用作爲營業收入,當客戶有權使用IP並開始從特許權中獲益時,需要根據借款人特定的、風險調整的利率計算的任何重大融資成分的影響進行調整,相關的利息收入或費用在有效利率基礎上逐漸確認。對於客戶超過最低保障的合同,公司在認爲客戶已超過最低時,確認任何額外按單位費用的營業收入,並一旦客戶報告實際使用情況,即對收入進行調整。

具有多個履行義務的IP授權合同

有時,公司會與多個履行義務的長期授權合同進行簽訂,這可能包括過去專利侵權索賠的和解或一個或多個未來的授權。在這些安排中,公司根據獨立銷售價格的相對價值,將交易價格分配給過去專利侵權索賠的和解和未來授權,這需要管理層進行重大判斷。

在確定每項履行義務的獨立銷售價格時,公司會考慮過去和未來預測的訂閱用戶數、出貨量和生產單位數量,以及公司通常從同類市場和地區的相似規模許可證持有者那裏獲得的每訂閱用戶或每單位的授權費率。

由於過去專利侵權索賠的和解一般在合同簽署時滿足,因此分配給過去專利侵權索賠和解的交易價格通常在合同生效的期間內被確認。分配給未來媒體IP授權的交易價格在授權期內按比例確認,而分配給未來半導體IP授權的交易價格則在合同簽署時確認。

12


 

實用的便捷措施和豁免

公司採取實用的便捷措施,不對合同是否包含重大財務組成部分進行評估,當營業收入確認的時間與現金收款的時間不同步時, 一年 或更少的時間內到期。

公司採取實用的便捷措施,將獲得客戶合同的費用作爲銷售、一般和行政費用在發生時計入,前提是攤銷期應爲 一年 或更少的時間內到期。

公司在披露預計來自未滿足的履約義務的收入時採取實用的便捷措施,排除原始持續時間少於的與客戶的合同 一年; 應歸屬的金額來源於 (i) 基於銷售或使用的知識產權許可的特許權使用費,或 (ii) 當變量全部分配給完全未滿足的履約義務時;或是對構成單一履約義務的完全未滿足的轉讓獨特商品或服務的承諾。

營業收入詳情

營業收入拆分

以下信息展示了營業收入和現金流的性質、金額、時間和不確定性是如何受到經濟因素影響的,通過按類別、市場垂直和地理位置(在“附註 15 –)進行拆分。 部門和地理信息這些信息包括來自客戶合同的營業收入和來自其他來源的收入,包括基於銷售或使用的特許權使用費和與過去侵權相關的費用。

經常性和非經常性營業收入

經常性營業收入包括以下內容:(i) 對於固定費用的媒體知識產權許可協議,與現有和未來專利技術的使用權相關的收入,從協議執行所在的報告期開始,到協議結束爲止,按直線法確認;以及 (ii) 對於每單位或每用戶的媒體知識產權或半導體知識產權特許使用費協議,與基於銷售或使用的特許使用費相關的收入,以換取知識產權的許可,按後續銷售或使用發生的期間確認。

非經常性營業收入包括以下內容:(i) 對於固定費用或最低保證的半導體知識產權許可協議,與使用知識產權相關的固定費用或最低保證收入,在協議執行時確認;以及 (ii) 對於所有許可協議,與針對過去專利侵權或許可的賠償相關的費用,在協議執行之前的報告期內,與每個賠償金額相對應的收入,在協議執行時確認。

按經常性和非經常性性質分解的營業收入如下(以千爲單位):

 

 

 

截至三個月
九月三十日

 

 

截至九個月
九月三十日

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

循環營業收入

 

$

82,704

 

 

$

83,595

 

 

$

249,844

 

 

$

255,078

 

非循環營業收入

 

 

3,397

 

 

 

17,802

 

 

 

7,012

 

 

 

46,843

 

總營業收入

 

$

86,101

 

 

$

101,397

 

 

$

256,856

 

 

$

301,921

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

13


 

Revenue by market vertical

Revenue disaggregated by market vertical was as follows (in thousands):

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Media

 

$

82,177

 

 

$

95,748

 

 

$

246,240

 

 

$

259,027

 

Semiconductor

 

 

3,924

 

 

 

5,649

 

 

 

10,616

 

 

 

42,894

 

Total revenue

 

$

86,101

 

 

$

101,397

 

 

$

256,856

 

 

$

301,921

 

Contract Balances

Contracts Assets

Contract assets primarily consist of unbilled contracts receivable that are expected to be received from customers in future periods, where the revenue recognized to date exceeds the amount billed. The amount of unbilled contracts receivable may not exceed their net realizable value and are classified as long-term assets if the payments are expected to be received more than one year from the reporting date. Contract assets also include the incremental costs of obtaining a contract with a customer, principally sales commissions when the renewal commission is not commensurate with the initial commission.

Contract assets were recorded in the Condensed Consolidated Balance Sheets as follows (in thousands):

 

 

 

September 30, 2024

 

 

December 31, 2023

 

Unbilled contracts receivable

 

$

101,593

 

 

$

74,919

 

Other current assets

 

 

701

 

 

 

620

 

Long-term unbilled contracts receivable

 

 

62,880

 

 

 

73,843

 

Other long-term assets

 

 

838

 

 

 

1,007

 

Total contract assets

 

$

166,012

 

 

$

150,389

 

Contract Liabilities

Contract liabilities are comprised of deferred revenue related to multi-period licensing arrangements for which the Company is paid in advance, while the underlying performance obligation is satisfied at a future date or over time.

Allowance for Credit Losses

The allowance for credit losses represents the Company’s best estimate of lifetime expected credit losses inherent in accounts receivable and unbilled contracts receivable. The Company’s long-term unbilled contracts receivable is derived from fixed-fee or minimum-guarantee Semiconductor IP licensing and is primarily comprised of contracts with large, well-capitalized companies. It is generally considered to be of high credit quality due to past collection history and the nature of the customers.

The allowance for credit losses at September 30, 2024 and December 31, 2023 was $0.7 million and $1.5 million, respectively and is presented as part of accounts receivable, net in the Condensed Consolidated Balance Sheets.

14


 

Additional Disclosures

The following table presents additional revenue and contract disclosures (in thousands):

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Revenue recognized in the period from:

 

 

 

 

 

 

 

 

 

 

 

 

Amounts included in deferred revenue at the beginning of the period

 

$

1,540

 

 

$

3,943

 

 

$

5,248

 

 

$

12,832

 

Performance obligations satisfied in previous periods (1)

 

$

3,137

 

 

$

16,896

 

 

$

6,127

 

 

$

13,143

 

 

(1) Performance obligations satisfied in previous periods consist mainly of fees associated with releases for past patent infringement, settlements of litigation during the period, and revenue from past royalties owed pursuant to expired or terminated IP license agreements. For long-term and multi-year revenue contracts, the Company recorded revenue from the releases for past infringement during the three and nine months ended September 30, 2024 and 2023 and expects to record revenue from the prospective license in future periods.

 

Remaining revenue under contracts with performance obligations represents the aggregate amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) under certain of the Company’s fixed fee arrangements (in thousands).

 

 

 

As of
September 30, 2024

 

Revenue from contracts with performance obligations expected to be satisfied in:

 

 

 

2024 (remaining 3 months)

 

$

43,042

 

2025

 

 

167,877

 

2026

 

 

71,113

 

2027

 

 

57,239

 

2028

 

 

48,631

 

Thereafter

 

 

59,651

 

Total

 

$

447,553

 

 

 

NOTE 4 – COMPOSITION OF CERTAIN FINANCIAL STATEMENT CAPTIONS

Other current assets consisted of the following (in thousands):

 

 

 

September 30, 2024

 

 

December 31, 2023

 

Prepaid income taxes

 

$

3,536

 

 

$

3,752

 

Prepaid expenses

 

 

1,954

 

 

 

2,185

 

Prepaid insurance

 

 

1,353

 

 

 

1,123

 

Other

 

 

3,142

 

 

 

640

 

Total other current assets

 

$

9,985

 

 

$

7,700

 

 

15


 

Property and equipment, net, consisted of the following (in thousands):

 

 

 

September 30, 2024

 

 

December 31, 2023

 

Equipment, furniture and other

 

$

17,065

 

 

$

17,267

 

Leasehold improvements

 

 

6,277

 

 

 

5,037

 

  Total property and equipment

 

 

23,342

 

 

 

22,304

 

Less: accumulated depreciation and amortization

 

 

(16,869

)

 

 

(15,333

)

Total property and equipment, net

 

$

6,473

 

 

$

6,971

 

 

Other long-term assets consisted of the following (in thousands):

 

 

 

September 30, 2024

 

 

December 31, 2023

 

Long-term deferred tax assets

 

$

25,704

 

 

$

23,885

 

Other assets

 

 

3,169

 

 

 

4,361

 

Total other long-term assets

 

$

28,873

 

 

$

28,246

 

Accrued liabilities consisted of the following (in thousands):

 

 

 

September 30, 2024

 

 

December 31, 2023

 

Employee compensation and benefits

 

$

8,699

 

 

$

8,378

 

Accrued expenses

 

 

3,750

 

 

 

3,601

 

Current portion of guarantee (1)

 

 

1,500

 

 

 

2,400

 

Current portion of operating lease liabilities

 

 

320

 

 

 

503

 

Accrued income taxes

 

 

47

 

 

 

325

 

Other

 

 

1,921

 

 

 

2,135

 

Total accrued liabilities

 

$

16,237

 

 

$

17,342

 

 

(1) Refer to “Note 14 Commitments and Contingencies” for further detail on the nature of the guarantee.

 

Other long-term liabilities consisted of the following (in thousands):

 

 

 

September 30, 2024

 

 

December 31, 2023

 

Long-term portion of guarantee (1)

 

$

15,583

 

 

$

16,135

 

Other

 

 

2,101

 

 

 

1,975

 

Total other long-term liabilities

 

$

17,684

 

 

$

18,110

 

 

(1) Refer to “Note 14 Commitments and Contingencies” for further detail on the nature of the guarantee.

16


 

NOTE 5 – FINANCIAL INSTRUMENTS

The Company has investments in debt securities, which include corporate bonds and notes, treasury and agency notes and bills, commercial paper, and in equity securities consisting of money market funds. The Company classifies its debt securities as available-for-sale (“AFS”), which are accounted for at fair value with credit related losses recognized as a provision for credit losses in its Consolidated Statements of Income and all non-credit related unrealized gains and losses recognized in accumulated other comprehensive income or loss on the Consolidated Balance Sheets. Under ASU 2016-01 (Topic 321), equity securities are measured at fair value with unrealized gains and losses recognized in other income and expense, net, in the Consolidated Statements of Income.

The following is a summary of marketable securities at September 30, 2024 and December 31, 2023 (in thousands):

 

 

 

September 30, 2024

 

 

 

Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Allowance for Credit Losses

 

 

Estimated
Fair
Values

 

Marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

$

3,645

 

 

$

3

 

 

$

 

 

$

 

 

$

3,648

 

Corporate bonds and notes

 

 

20,446

 

 

 

182

 

 

 

(2

)

 

 

 

 

 

20,626

 

Treasury and agency notes and bills

 

 

4,704

 

 

 

7

 

 

 

-

 

 

 

 

 

 

4,711

 

Total debt securities

 

 

28,795

 

 

 

192

 

 

 

(2

)

 

 

 

 

 

28,985

 

Money market funds

 

 

7,169

 

 

 

 

 

 

 

 

 

 

 

 

7,169

 

Total equity securities

 

 

7,169

 

 

 

 

 

 

 

 

 

 

 

 

7,169

 

Total marketable securities

 

$

35,964

 

 

$

192

 

 

$

(2

)

 

$

 

 

$

36,154

 

Reported in:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

$

7,668

 

Marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

$

28,486

 

Total marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

$

36,154

 

 

 

 

December 31, 2023

 

 

 

Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Allowance for Credit Losses

 

 

Estimated
Fair
Values

 

Marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

$

12,421

 

 

$

5

 

 

$

(4

)

 

$

 

 

$

12,422

 

Treasury and agency notes and bills

 

 

10,746

 

 

 

 

 

 

(1

)

 

 

 

 

 

10,745

 

Corporate bonds and notes

 

 

5,813

 

 

 

34

 

 

 

(2

)

 

 

 

 

 

5,845

 

Total debt securities

 

 

28,980

 

 

 

39

 

 

 

(7

)

 

 

 

 

 

29,012

 

Money market funds

 

 

5,778

 

 

 

 

 

 

 

 

 

 

 

 

5,778

 

Total equity securities

 

 

5,778

 

 

 

 

 

 

 

 

 

 

 

 

5,778

 

Total marketable securities

 

$

34,758

 

 

$

39

 

 

$

(7

)

 

$

 

 

$

34,790

 

Reported in:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

$

5,778

 

Marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

$

29,012

 

Total marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

$

34,790

 

 

17


 

 

At September 30, 2024 and December 31, 2023, the Company had $89.2 million and $83.6 million, respectively, in cash and cash equivalents and short-term investments. A portion of these amounts was held in marketable securities, as shown above. The remaining balances of $53.0 million and $48.8 million at September 30, 2024 and December 31, 2023, respectively, consisted of cash held in operating accounts not included in the tables above.

Debt Securities

The gross realized gains and losses on sales of marketable debt securities were immaterial during the three and nine months ended September 30, 2024 and 2023. Unrealized losses on AFS debt securities were immaterial as of September 30, 2024 and December 31, 2023. The Company evaluated whether the decline in fair value has resulted from credit losses or other factors and concluded these amounts were related to temporary fluctuations in value of AFS securities and were due primarily to changes in interest rates and market conditions of the underlying securities. The Company did not recognize a provision for credit losses related to its AFS debt securities during the three and nine months ended September 30, 2024 and 2023, respectively.

The estimated fair value of AFS debt securities by contractual maturity at September 30, 2024 is shown below (in thousands). Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations without call or prepayment penalties.

 

 

 

Amortized
Cost

 

Estimated
Fair Value

 

Due in one year or less

 

$

15,822

 

$

15,855

 

Due in one to two years

 

 

8,956

 

 

9,064

 

Due in two to three years

 

 

4,017

 

 

4,066

 

Total

 

$

28,795

 

$

28,985

 

 

NOTE 6 – FAIR VALUE

The Company follows the authoritative guidance for fair value measurement and the fair value option for financial assets and financial liabilities. The Company carries its financial instruments at fair value with the exception of its long-term debt. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, or an exit price, in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The established fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:

 

Level 1

Quoted prices in active markets for identical assets.

 

 

Level 2

Observable market-based inputs or unobservable inputs that are corroborated by market data.

 

 

Level 3

Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.

When applying fair value principles in the valuation of assets, the Company is required to maximize the use of quoted market prices and minimize the use of unobservable inputs. The Company calculates the fair value of its Level 1 and Level 2 instruments based on the exchange traded price of similar or identical instruments, where available, or based on other observable inputs. There were no transfers into or out of Level 1 or Level 2 that occurred between December 31, 2023 and September 30, 2024.

18


 

The following sets forth the fair value, and classification within the hierarchy, of the Company’s assets required to be measured at fair value on a recurring basis as of September 30, 2024 (in thousands):

 

 

 

Fair Value

 

 

Quoted
Prices in
Active Markets
for Identical
Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper - debt securities (1)

 

$

3,648

 

 

$

 

 

$

3,648

 

 

$

 

Treasury and agency notes and bills - debt securities (1)

 

 

4,711

 

 

 

 

 

 

4,711

 

 

 

 

Corporate bonds and notes - debt securities (2)

 

 

20,626

 

 

 

 

 

 

20,626

 

 

 

 

Money market funds - equity securities (3)

 

 

7,169

 

 

 

7,169

 

 

 

 

 

 

 

Total Assets

 

$

36,154

 

 

$

7,169

 

 

$

28,985

 

 

$

 

 

(1)
Reported as AFS debt securities in the Condensed Consolidated Balance Sheet as these were purchased with original maturities of more than three months at date of purchase; otherwise reported as cash and cash equivalents.
(2)
Reported as AFS debt securities in the Condensed Consolidated Balance Sheet.
(3)
Reported as cash and cash equivalents in the Condensed Consolidated Balance Sheet.

The following sets forth the fair value, and classification within the hierarchy, of the Company’s assets required to be measured at fair value on a recurring basis as of December 31, 2023 (in thousands):

 

 

 

Fair Value

 

 

Quoted
Prices in
Active Markets
for Identical
Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper - debt securities (1)

 

$

12,422

 

 

$

 

 

$

12,422

 

 

$

 

Treasury and agency notes and bills - debt securities (1)

 

 

10,745

 

 

 

 

 

 

10,745

 

 

 

 

Corporate bonds and notes - debt securities (2)

 

 

5,845

 

 

 

 

 

 

5,845

 

 

 

 

Money market funds - equity securities (3)

 

 

5,778

 

 

 

5,778

 

 

 

 

 

 

 

Total Assets

 

$

34,790

 

 

$

5,778

 

 

$

29,012

 

 

$

 

 

(1)
Reported as AFS debt securities in the Condensed Consolidated Balance Sheet as these were purchased with original maturities of more than three months at date of purchase; otherwise reported as cash and cash equivalents.
(2)
Reported as AFS debt securities in the Condensed Consolidated Balance Sheet.
(3)
Reported as cash and cash equivalents in the Condensed Consolidated Balance Sheet.

 

19


 

Financial Instruments Not Recorded at Fair Value

The Company’s long-term debt is carried at amortized cost and is measured at fair value on a quarterly basis for disclosure purposes. The carrying amounts and estimated fair values are as follows (in thousands):

 

 

 

September 30, 2024

 

 

December 31, 2023

 

 

 

Carrying
Amount

 

 

Estimated
Fair Value

 

 

Carrying
Amount

 

 

Estimated
Fair Value

 

2021 Refinanced Term Loan B (1)

 

 

 

 

 

 

 

 

585,695

 

 

 

584,231

 

2024 Term Loan B (1)

 

 

524,424

 

 

 

524,424

 

 

 

 

 

 

 

Total long-term debt, net

 

$

524,424

 

 

$

524,424

 

 

$

585,695

 

 

$

584,231

 

(1) Carrying amounts of long-term debt are net of unamortized debt discount and issuance costs of $12.7 million and $15.6 million as of September 30, 2024 and December 31, 2023, respectively. See “Note 8 – Debt” for additional information.

If reported at fair value in the Condensed Consolidated Balance Sheets, the Company’s debt would be classified within Level 2 of the fair value hierarchy. The fair value of the debt was estimated based on the quoted market prices for the same or similar issues.

NOTE 7 – GOODWILL AND IDENTIFIED INTANGIBLE ASSETS

Goodwill

The carrying value of goodwill at September 30, 2024 and December 31, 2023 was $313.7 million. There were no changes to the carrying value of goodwill from January 1, through September 30, 2024. Goodwill at each reporting unit is evaluated for potential impairment annually, as of the beginning of the fourth quarter, and whenever events or changes in circumstances indicate the carrying amount of goodwill may not be recoverable. The process of evaluating goodwill for potential impairment is subjective and requires significant estimates, assumptions and judgments particularly related to the identification of reporting units, the assignment of assets and liabilities to reporting units and estimating the fair value of each reporting unit. No impairment charges were recognized during the three and nine months ended September 30, 2024 and 2023.

Identified Intangible Assets

Identified intangible assets consisted of the following (in thousands):

 

 

Average

 

September 30, 2024

 

 

December 31, 2023

 

 

 

Life
(Years)

 

Gross
Assets

 

 

Accumulated
Amortization

 

 

Net

 

 

Gross
Assets

 

 

Accumulated
Amortization

 

 

Net

 

Finite-lived intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquired patents / core technology

 

3-10

 

$

661,336

 

 

$

(363,975

)

 

$

297,361

 

 

$

654,360

 

 

$

(323,261

)

 

$

331,099

 

Customer contracts and related relationships

 

3-9

 

 

155,900

 

 

 

(155,900

)

 

 

 

 

 

155,900

 

 

 

(139,827

)

 

 

16,073

 

Existing technology / content database

 

5-10

 

 

38,681

 

 

 

(38,681

)

 

 

 

 

 

38,681

 

 

 

(38,681

)

 

 

 

Trademarks/trade name

 

4-10

 

 

1,300

 

 

 

(1,300

)

 

 

 

 

 

1,300

 

 

 

(1,300

)

 

 

 

Total intangible assets

 

 

 

$

857,217

 

 

$

(559,856

)

 

$

297,361

 

 

$

850,241

 

 

$

(503,069

)

 

$

347,172

 

 

20


 

As of September 30, 2024, the estimated future amortization expense of total finite-lived intangible assets was as follows (in thousands):

 

 

 

Amounts

 

2024 (remaining 3 months)

 

$

13,601

 

2025

 

 

54,397

 

2026

 

 

54,263

 

2027

 

 

53,911

 

2028

 

 

48,868

 

Thereafter

 

 

72,321

 

Total

 

$

297,361

 

 

NOTE 8 – DEBT

The outstanding amounts of debt were as follows (in thousands):

 

 

 

September 30, 2024

 

 

December 31, 2023

 

2021 Refinanced Term Loan B

 

 

 

 

$

601,250

 

2024 Term Loan B

 

$

537,097

 

 

 

 

Unamortized debt discount and issuance costs

 

 

(12,673

)

 

 

(15,555

)

 

 

 

524,424

 

 

 

585,695

 

Less: current portion, net of debt discount and issuance costs

 

 

(24,732

)

 

 

(66,145

)

Total long-term debt, net of current portion

 

$

499,692

 

 

$

519,550

 

Term Loan B

On June 8, 2021, the Company entered into Amendment No. 1 (“Amendment No. 1”) to that certain Credit Agreement dated June 1, 2020 by and among the Company, the lenders party thereto and Bank of America, N.A., as administrative agent and collateral agent (the “2020 Credit Agreement”). The 2020 Credit Agreement initially provided for a five-year senior secured term loan B facility in an aggregate principal amount of $1,050 million (the “2020 Term Loan B Facility”). Amendment No. 1 provided for, among other things, (i) a new tranche of term loans (the “2021 Refinanced Term Loan B”) in an aggregate principal amount of $810.0 million, (ii) a reduction of the interest rate margin applicable to such loans to (x) in the case of base rate loans, 2.50% per annum and (y) in the case of Eurodollar loans, LIBOR plus a margin of 3.50% per annum, (iii) a prepayment premium of 1.00% in connection with any repricing transaction with respect to the 2021 Refinanced Term Loan B within six months of the closing date of Amendment No. 1, (iv) an extension of the maturity to June 8, 2028, and (v) certain additional amendments, including amendments to provide the Company with additional flexibility under the covenant governing restricted payments.

On May 30, 2023, the Company entered into Amendment No. 2 (“Amendment No. 2”) to the 2020 Credit Agreement, to replace the reference to LIBOR as the base rate with the reference to the Secured Overnight Financing Rate “SOFR” as administered by the Federal Reserve Bank of New York. The new reference rate was effective July 1, 2023.

On May 20, 2024, the Company entered into Amendment No. 3 (“Amendment No. 3”) to the 2020 Credit Agreement, which provided for, among other things, (i) a repricing of the 2020 Term Loan B Facility through a refinancing of the entire amount of the 2021 Refinanced Term Loan B with a new tranche of term loans (the “2024 Term Loan B”) in an aggregate principal amount of $561.1 million, (ii) a reduction of the interest rate margin applicable to such loans to (x) in the case of SOFR loans, SOFR plus a margin of 3.00% per annum and (y) in the case of base rate loans, 2.00% per annum, (iii) a reduction in the excess cash flow mandatory payment thresholds

21


 

and (iv) a prepayment premium of 1.00% in connection with any repricing transaction with respect to the 2024 Term Loan B within six months of the closing date of Amendment No. 3. The 2024 Term Loan B will mature on June 8, 2028, the same date upon which the 2021 Refinanced Term Loan B matured prior to giving effect to Amendment No. 3.

The obligations under the 2020 Credit Agreement, inclusive of any changes by Amendment No. 1, Amendment No. 2 and Amendment No. 3, continue to be guaranteed by the Company’s wholly-owned material domestic subsidiaries (collectively, the “Guarantors”) and continue to be secured by a lien on substantially all of the assets of the Company and the Guarantors.

The 2020 Credit Agreement, as amended, contains customary events of default, upon the occurrence of which, after any applicable cure period, the lenders will have the ability to accelerate all outstanding loans thereunder. The 2020 Credit Agreement, as amended, also contains customary representations and warranties and affirmative and negative covenants that, among other things and subject to certain exceptions, restrict the ability of the Company and its subsidiaries to create or incur certain liens, incur or guarantee additional indebtedness, merge or consolidate with other companies, transfer or sell assets and make restricted payments. The Separation did not require the Company to obtain any waivers under the 2020 Credit Agreement, and the Company completed the Separation in compliance with all of the covenants contained in the 2020 Credit Agreement. The 2020 Credit Agreement, as amended, requires the Company to maintain a total net leverage ratio of no greater than 3.00x in order access an annual basket from which to make restricted payments (such as dividend payments and share repurchases). The Company was in compliance with all requirements as of September 30, 2024. The 2020 Credit Agreement, as amended, also requires the Company to continue to make cash payments on an annual basis based on certain leverage ratios and excess cash flow generated for the immediately preceding fiscal year. The cash payments are applied to the remaining principal balance due at final maturity.

Interest Expense and Expected Principal Payments

At September 30, 2024, the Company had $537.1 million in total debt outstanding. There were also $12.7 million of unamortized debt discount and issuance costs recorded as a reduction from the carrying amount of the debt. The interest rate on the 2024 Term Loan B as of September 30, 2024, including the amortization of debt discount and issuance costs, was 9.2% and interest is payable monthly. Interest expense was $12.5 million and $39.6 million for the three and nine months ended September 30, 2024, respectively. Interest expense was $15.5 million and $46.8 million for the three and nine months ended September 30, 2023, respectively. Amortized debt discount and issuance costs, which were included in interest expense, amounted to $0.9 million and $2.4 million for the three and nine months ended September 30, 2024, respectively, and $1.0 million and $3.3 million for the three and nine months ended September 30, 2023, respectively.

As of September 30, 2024, future minimum principal payments for long-term debt, excluding any additional principal payment required by the excess cash flow provision, are summarized as follows (in thousands):

 

 

 

Amounts

 

2024 (remaining 3 months)

 

$

7,014

 

2025

 

 

28,056

 

2026

 

 

28,056

 

2027

 

 

28,057

 

2028

 

 

445,914

 

Total

 

$

537,097

 

 

22


 

NOTE 9 – NET INCOME PER SHARE

The following table sets forth the computation of net income per share (in thousands, except per share amounts):

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

19,314

 

 

$

24,232

 

 

$

28,595

 

 

$

54,672

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock outstanding

 

 

109,035

 

 

 

106,902

 

 

 

108,491

 

 

 

106,322

 

Add: Effect of dilutive securities associated with options

 

 

 

 

 

1

 

 

 

2

 

 

 

 

Add: Effect of dilutive securities associated with restricted stock awards and units

 

 

4,086

 

 

 

6,025

 

 

 

4,383

 

 

 

6,442

 

Add: Effect of dilutive securities associated with employee stock purchase program

 

 

3

 

 

 

1

 

 

 

5

 

 

 

1

 

Weighted average common shares - dilutive

 

 

113,124

 

 

 

112,929

 

 

 

112,881

 

 

 

112,765

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic net income per share

 

$

0.18

 

 

$

0.23

 

 

$

0.26

 

 

$

0.51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted net income per share

 

$

0.17

 

 

$

0.21

 

 

$

0.25

 

 

$

0.48

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Anti-dilutive employee stock-based awards, excluded

 

 

632

 

 

 

665

 

 

 

736

 

 

 

591

 

Basic net income per share is computed using the weighted average number of shares of common stock outstanding during the period, excluding any unvested restricted stock units that are subject to repurchase. Diluted net income per share is computed using the treasury stock method to calculate the weighted average number of shares of common stock and, if dilutive, potential common shares outstanding during the period. Potentially dilutive common shares include unvested restricted stock units and incremental common shares issuable upon the exercise of stock options, less shares repurchased from assumed proceeds. The assumed proceeds calculation includes actual proceeds to be received from the employee upon exercise and the average unrecognized stock compensation cost during the period.

NOTE 10 – STOCKHOLDERS’ EQUITY

Equity Incentive Plans

The 2020 EIP

On June 1, 2020, the Company adopted the 2020 Equity Incentive Plan (the “2020 EIP”). Under the 2020 EIP, the Company may grant equity-based awards to employees, non-employee directors, and consultants for services rendered to the Company (or any parent or subsidiary) in the form of stock options, stock awards, restricted stock awards, restricted stock units, stock appreciation rights, dividend equivalents and performance awards (or any combination thereof).

At the Company’s 2024 Annual Stockholders Meeting on May 9, 2024, the Company’s stockholders approved an amendment and restatement of the 2020 EIP, which provided for (i) an increase of the number of shares reserved for issuance by 8,900,000 (from an initial share reserve of 16,800,000 under the prior 2020 EIP to 25,700,000 under the amended and restated 2020 EIP) and (ii) the removal of the “fungible share ratio” for future awards, such that all equity awards granted on or after May 9, 2024 will count on a one-to-one basis against the number of shares authorized for issuance under the 2020 EIP (whereas each share granted pursuant to “full value”

23


 

awards (i.e. stock awards, restricted stock awards, restricted stock units, performance awards and dividend equivalents) prior to May 9, 2024 are counted against shares available for issuance on a 1.5 to 1 ratio). As of September 30, 2024, there were approximately 8.1 million shares reserved for future grants under the 2020 EIP.

The 2020 EIP provides for option grants designed as either incentive stock options or non-statutory options. Options generally are granted with an exercise price not less than the value of the common stock on the grant date and have a term of ten years from the date of grant and vest over a four-year period.

The vesting criteria for restricted stock awards and restricted stock units is generally the passage of time or meeting certain performance-based objectives, and continued employment through the vesting period, which is generally four years for time-based awards.

Assumed Plans

On June 1, 2020, the Company assumed all then-outstanding stock options, awards, and shares available and reserved for issuance under all legacy Equity Incentive Plans of TiVo (collectively, the “Assumed Plans”). Stock options assumed from the Assumed Plans generally have vesting periods of four years and a contractual term of seven years. Awards of restricted stock and restricted stock units assumed from the Assumed Plans are generally subject to a four year vesting period. The Company has not issued any awards under these plans since the 2020 EIP was amended in 2022. The number of shares subject to stock options and restricted stock units outstanding under these plans are included in the tables below.

A summary of the stock option activity is presented below (in thousands, except per share amounts):

 

 

 

Options Outstanding

 

 

 

Number of
Shares
Subject
to Options

 

 

Weighted
Average
Exercise
Price Per
Share

 

Balance at December 31, 2023

 

 

213

 

 

$

14.26

 

Options granted

 

 

 

 

$

 

Options exercised

 

 

(53

)

 

$

10.62

 

Options canceled / forfeited / expired

 

 

(27

)

 

$

12.39

 

Balance at September 30, 2024

 

 

133

 

 

$

16.06

 

Vested and exercisable at September 30, 2024

 

 

133

 

 

$

16.06

 

 

24


 

Restricted Stock Awards

Information with respect to outstanding restricted stock units (including both time-based vesting and performance-based vesting) as of September 30, 2024 is as follows (in thousands, except per share amounts):

 

 

 

Restricted Stock Awards

 

 

 

Number of
Shares
Subject to
Time-
based Vesting

 

 

Number of
Shares
Subject to
Performance-
based Vesting

 

 

Total
Number of
Shares

 

 

Weighted
Average
Grant Date
Fair Value
Per Share

 

Balance at December 31, 2023

 

 

7,591

 

 

 

1,781

 

 

 

9,372

 

 

$

10.44

 

Awards granted

 

 

2,196

 

 

 

945

 

 

 

3,141

 

 

$

12.03

 

Awards vested / earned

 

 

(2,634

)

 

 

 

 

 

(2,634

)

 

$

9.76

 

Awards canceled / forfeited

 

 

(586

)

 

 

(479

)

 

 

(1,065

)

 

$

12.95

 

Balance at September 30, 2024

 

 

6,567

 

 

 

2,247

 

 

 

8,814

 

 

$

10.92

 

Performance Awards

Performance awards may be granted to employees or consultants based upon, among other things, the contributions, responsibilities and other compensation of the particular employee or consultant. The value and the vesting of such performance awards are generally linked to one or more performance goals or certain market conditions determined by the Company, in each case on a specified date or dates or over any period or periods determined by the Company, and may range from zero to 200 percent of the grant. For performance awards subject to a market vesting condition (“market-based PSUs”), the fair value per award is fixed at the grant date and the amount of compensation expense is not adjusted during the performance period regardless of changes in the level of achievement of the market condition.

Employee Stock Purchase Plans

On June 1, 2020, the Company adopted the 2020 Employee Stock Purchase Plan (the “2020 ESPP”). The 2020 ESPP is implemented through consecutive overlapping 24-month offering periods, each of which is comprised of four six-month purchase periods. The first offering period commenced on September 1, 2020 and ended on August 31, 2022. Due to the Separation, the next offering period under the 2020 ESPP plan commenced on December 1, 2022. Each subsequent offering period under the 2020 ESPP will be twenty-four (24) months long and will commence on each December 1 with four six-month purchase periods. Participants may contribute up to 100% of their base earnings and commissions through payroll deductions, and the accumulated deductions will be applied to the purchase of shares on each semi-annual purchase date. The purchase price per share will equal 85% of the fair market value per share on the start date of the offering period or, if lower, 85% of the fair market value per share on the semi-annual purchase date.

An eligible employee’s right to buy the Company’s common stock under the 2020 ESPP may not accrue at a rate in excess of $25,000 of the fair market value of such shares per calendar year for each calendar year of an offering period. If the fair market value per share of the Company’s common stock on any purchase date during an offering period is less than the fair market value per share on the start date of the 24-month offering period, then that offering period will automatically terminate and a new 24-month offering period will begin on the next business day. All participants in the terminated offering will be transferred to the new offering period.

At the 2022 Annual Stockholders Meeting on April 29, 2022, the Company’s stockholders approved an amendment to the 2020 ESPP and increased by 6.0 million the number of shares reserved for issuance. As of September 30, 2024, there were approximately 5.2 million shares reserved for grant under the Company’s 2020 ESPP.

25


 

Modification of Equity Awards

In connection with the Separation and under the provisions of the existing plans described above, the Company’s outstanding stock options and equity awards were converted to units denominated in the equity of the Company, Xperi Inc., or both. The number of units and exercise prices of outstanding stock options and equity awards were converted based on the conversion ratios established in the Employee Matters Agreement that the Company entered into in connection with the Separation. The intent of the conversion ratios was to preserve the value of the awards immediately before and after the Separation. Upon the Separation, employees holding stock options and equity awards denominated in the Company’s pre-Separation stock received a number of otherwise-similar stock options and awards in post-Separation Company’s stock and/or Xperi Inc.’s stock based on the conversion ratios outlined for each group of employees. For purposes of the vesting of these equity awards, continued employment or service with the Company or with Xperi Inc. is treated as continued employment for purposes of both the Company’s and Xperi Inc.’s equity awards and the vesting terms of each converted grant remained unchanged. There were no changes to the plan terms described above with the exception that the price on the grant date, or October 1, 2022 was adjusted to exclude the value of Xperi Inc. based on the conversion ratios applied to other equity awards.

Dividends

Stockholders of the Company’s common stock are entitled to receive dividends when declared by the Company’s board of directors (the “Board”). During the periods ended September 30, 2024 and 2023, quarterly dividends declared were $0.05 per common share, respectively. The capacity to pay dividends in the future depends on many factors, including the Company’s financial condition, results of operations, capital requirements, capital structure, industry practice and other business conditions that the Board considers relevant.

Stock Repurchase Programs

On June 12, 2020 the Board authorized a new stock repurchase program providing for the repurchase of up to $150.0 million of the Company’s Common Stock dependent on market conditions, share prices and other factors. On April 22, 2021, the Board authorized an additional $100.0 million of purchases under the existing stock repurchase plan.

There were no shares repurchased during the three and nine months ended September 30, 2024. As of September 30, 2024, the Company had repurchased a total of approximately 10.0 million shares of common stock, since inception of the plan, at an average price of $17.24 per share for a total cost of $172.2 million. The shares repurchased are recorded as treasury stock and are accounted for under the cost method. No expiration date has been specified for this plan. As of September 30, 2024, the total remaining amount available for repurchase under this plan was $77.8 million. The Company may execute authorized repurchases from time to time under the plan.

The Company accounts for stock repurchases using the cost method and records retirement of treasury stock as a reduction of the cumulative treasury stock paid-in capital balance. Once the cumulative balance is reduced to zero, any remaining difference resulting from the retirement of treasury stock is recorded as a reduction of retained earnings.

The Company issues restricted stock awards as part of the equity incentive plans described above. For the majority of restricted awards, shares are withheld to satisfy required withholding taxes at the vesting date. Shares withheld to satisfy required withholding taxes in connection with the vesting of restricted awards are treated as common stock repurchases in the Condensed Consolidated Financial Statements because they reduce the number of shares that would have been issued on vesting. However, these withheld shares are not included in common stock repurchases under the Company’s authorized share repurchase plan.

26


 

NOTE 11 – STOCK-BASED COMPENSATION EXPENSE

The effect of recording stock-based compensation (“SBC”) expense for the three and nine months ended September 30, 2024 and 2023 is as follows (in thousands):

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Research and development

 

$

1,126

 

 

$

767

 

 

 

3,028

 

 

 

2,097

 

Selling, general and administrative

 

 

6,293

 

 

 

4,107

 

 

 

16,128

 

 

 

10,973

 

Total stock-based compensation expense

 

$

7,419

 

 

$

4,874

 

 

$

19,156

 

 

$

13,070

 

There were no options granted during the three and nine months ended September 30, 2024 and 2023.

The Company uses a Monte Carlo simulation to determine the grant date fair value of performance stock awards subject to market conditions, or market-based PSUs. The following assumptions were used to value the restricted stock units subject to market conditions granted during the nine months ended September 30, 2024 and 2023:

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

Expected life (years)

 

 

3.0

 

 

 

3.0

 

Risk-free interest rate

 

 

4.5

%

 

3.6% - 4.5%

 

Dividend yield

 

 

1.8

%

 

1.9% - 2.3%

 

Expected volatility

 

 

57.0

%

 

63.3% - 68.5%

 

Grants under the 2020 ESPP occur in June and December, as discussed in “Note 10 – Stockholders’ Equity”. The following assumptions were used to value the shares for these grants during the nine months ended September 30, 2024 and 2023:

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

Expected life (years)

 

 

2.0

 

 

 

2.0

 

Risk-free interest rate

 

 

4.8

%

 

 

4.3

%

Dividend yield

 

 

1.7

%

 

 

2.0

%

Expected volatility

 

 

57.0

%

 

 

63.5

%

 

NOTE 12 – INCOME TAXES

The Company’s income tax provision and effective tax rate for interim periods are based on its estimated annual effective tax rate adjusted for discrete items during the period. For the three and nine months ended September 30, 2024, the Company recorded income tax benefit of $(2.5) million and expense of $6.1 million, respectively. For the three and nine months ended September 30, 2023, the Company recorded income tax expense of $1.7 million and $15.9 million, respectively. The effective tax rate varies from the 21% U.S. federal tax rate primarily due to unrealized foreign exchange gain or loss on prior year South Korea withholding tax refund claims. The decrease in income tax expense for the nine months ended September 30, 2024, as compared to the same period in the prior year was primarily due to certain unrealized foreign exchange benefits associated with South Korea withholding tax refund claims.

27


 

 

NOTE 13 – LEASES

The Company leases office and research facilities and office equipment under operating leases which expire through 2032. The Company’s leases have remaining lease terms of less than one year to eight years, some of which may include options to extend the leases for five years or longer, and some of which may include options to terminate the leases within the next five years or less. Leases with an initial term of 12 months or less are not recorded on the Consolidated Balance Sheets; expense for these leases is recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred and are not included within the lease liability and right-of-use assets calculation. As a practical expedient, the Company elected, for all office and facility leases, not to separate non-lease components (e.g., common-area maintenance costs) from lease components (e.g., fixed payments including rent) and instead to account for each separate lease component and its associated non-lease components as a single lease component.

As most of the leases do not provide an implicit rate, the Company generally, for purposes of discounting lease payments, uses its incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date.

The components of operating lease costs were as follows (in thousands):

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Fixed lease cost

 

$

512

 

 

$

561

 

 

$

1,535

 

 

 

1,671

 

Variable lease cost

 

 

207

 

 

 

171

 

 

 

689

 

 

 

468

 

Total operating lease cost

 

$

719

 

 

$

732

 

 

$

2,224

 

 

$

2,139

 

Other information related to leases was as follows (in thousands, except lease term and discount rate):

 

 

 

Three Months Ended
September 30,

 

 

 

2024

 

 

2023

 

Cash paid for amounts included in the measurement of lease liabilities:

 

 

 

 

 

 

Operating cash flows from operating leases

 

$

502

 

 

$

611

 

 

 

 

 

September 30, 2024

 

 

December 31, 2023

 

Weighted-average remaining lease term (years):

 

 

 

 

 

 

Operating leases

 

 

7.72

 

 

 

8.35

 

Weighted-average discount rate:

 

 

 

 

 

 

Operating leases

 

 

8.6

%

 

 

8.5

%

 

28


 

 

Future minimum lease payments and related lease liabilities as of September 30, 2024 were as follows (in thousands):

 

 

 

Operating Lease Payments (1)

 

2024 (remaining 3 months)

 

$

502

 

2025

 

 

87

 

2026

 

 

1,709

 

2027

 

 

2,132

 

2028

 

 

1,887

 

Thereafter

 

 

7,772

 

Total lease payments

 

 

14,089

 

Less: imputed interest

 

 

(4,589

)

Present value of lease liabilities:

 

$

9,500

 

 

 

 

 

Less: current obligations under leases (accrued liabilities)

 

 

320

 

Noncurrent operating lease liabilities

 

$

9,180

 

(1) Future minimum lease payments exclude short-term leases as well as payments to landlords for variable common area maintenance, insurance and real estate taxes.

NOTE 14 – COMMITMENTS AND CONTINGENCIES

 

Purchase and Other Contractual Obligations

In the ordinary course of business, the Company enters into contractual agreements with third parties that include non-cancelable payment obligations, for which it is liable in future periods. These arrangements primarily include unconditional purchase obligations to service providers. As of September 30, 2024, the Company’s total future unconditional purchase obligations were approximately $6.0 million, including $1.6 million due in the remainder of 2024, $2.3 million due in 2025 and $2.1 million due thereafter.

Guarantee

Prior to the Separation, Adeia Media LLC, a subsidiary of the Company (“Adeia Media”), and a subsidiary of Xperi Inc. (“Xperi Sub”) entered into an agreement (the “Specified Agreement”) with a third party pursuant to which Adeia Media guarantees the performance of Xperi Sub under the Specified Agreement, including its payment obligations to such third party. In connection with the Separation, Adeia Media and Xperi Sub entered into a separate cross business agreement (the “Cross Business Agreement”) effective as of October 1, 2022, under which Adeia Media agreed to make guarantee payments to Xperi Sub in amounts based on certain of its operating expenses and other minimum performance obligations under the Specified Agreement through 2031. Consequently, on October 1, 2022, the Company recognized a guarantee liability pursuant to ASC 460 “Guarantees” of $19.7 million, which represents the fair value of Adeia Media’s projected payments of such operating expenses during the term of the Cross Business Agreement. Subsequent changes to the carrying value of the guarantee are recognized as part of the Company’s results of operations. The maximum potential amount of future payments subject to the guarantee is approximately $7.5 million per annum between 2024 and 2031.

As of September 30, 2024 and December 31, 2023, the balance of the guarantee liability was $17.1 million and 18.5 million, respectively.

29


 

Indemnifications

In the normal course of business, the Company provides indemnifications of varying scopes and amounts to certain of its licensees, customers, and business partners against claims made by third parties arising from the use of the Company’s intellectual property, services or technologies. The Company cannot reasonably estimate the possible range of losses that may be incurred pursuant to its indemnification obligations, if any. Variables affecting any such assessment include, but are not limited to: the nature of the claim asserted; the relative merits of the claim; the financial ability of the party suing the indemnified party to engage in protracted litigation; the number of parties seeking indemnification; the nature and amount of damages claimed by the party suing the indemnified party; and the willingness of such party to engage in settlement negotiations. To date, no such claims have been filed against the Company and no liability has been recorded in the Company’s financial statements.

As permitted under Delaware law, the Company has agreements whereby it indemnifies its officers and directors for certain events or occurrences while the officer or director is, or was, serving at the Company’s request in such capacity. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company believes, given the absence of any such payments in the Company’s history, and the estimated low probability of such payments in the future, that the estimated fair value of these indemnification agreements is immaterial. In addition, the Company has directors’ and officers’ liability insurance coverage that is intended to reduce its financial exposure and may enable the Company to recover any payments under the indemnification agreements, should they occur.

Contingencies

At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of losses is probable and reasonably estimable under the provisions of the authoritative guidance that addresses accounting for contingencies.

Litigation related

On June 23, 2017, Adeia Guides Inc. (formerly known as Rovi Guides, Inc.) and Adeia Media Solutions Inc. (formerly known as TiVo Solutions Inc.) (together, “Adeia Media”) filed a patent infringement complaint against Videotron Ltd. and Videotron G.P. (together, “Videotron”) in Toronto, Canada, alleging infringement of six patents. On June 10, 2022, the Federal Court of Canada issued its decision in the case finding in favor of Videotron and its legacy “illico” platform. Specifically, the Court found invalid each of the asserted claims related to the four remaining patents involved in the case. In Canada, the prevailing party in patent litigation is entitled to reimbursement of certain of its costs and expenses. Accordingly, the Company paid $2.5 million for expense reimbursement in the fourth quarter of 2022. On September 12, 2022, Adeia Media filed a notice of appeal with the Federal Court of Appeal of Canada appealing the decision of the Federal Court of Canada. On January 30, 2023, Adeia Media filed its opening memorandum of fact and law. Videotron filed its memorandum of fact and law on April 17, 2023. On November 28, 2023, the Federal Court of Appeal of Canada held a hearing on the appeal and took the matter under reserve. On August 6, 2024, the Federal Court of Appeal of Canada issued a judgment in the appeal in which it dismissed the appeal.

On January 19, 2018, Adeia Media filed a patent infringement complaint against Bell Canada (and four of its affiliates) (collectively, “Bell”) in Toronto, Canada, alleging infringement of six patents. On February 2, 2018, Adeia Media filed a patent infringement complaint against Telus Corporation (and two of its affiliates) (collectively, “Telus”) in Toronto, Canada, alleging infringement of the same six patents. Bell 1 and Telus 1 (each as defined herein) were heard together for purposes of pre-trial and trial proceedings. On October 7, 2022, the Federal Court of Canada issued its decision in the two cases finding in favor of Bell and Telus and their respective IPTV services, Bell Fibe TV and Telus Optik TV. Specifically, the Court found invalid each of the asserted claims of the four remaining patents involved in the case. In Canada, the prevailing party in patent litigation is entitled to reimbursement of certain of its costs and expenses. Accordingly, the Company paid $2.8 million for expense reimbursement in the second quarter of 2023. On November 7, 2022, Adeia Media filed a notice of appeal with the Federal Court of Appeal of Canada appealing the decision of the Federal Court of Canada. On June 2, 2023, Adeia Media filed its opening memorandum of fact and law. Bell and Telus filed a combined memorandum of fact and law on August 18, 2023. On November 29, 2023, the Federal Court of Appeal of Canada held a hearing on the appeal and took the matter under reserve. On August 6, 2024, the Federal Court of Appeal of Canada issued a judgment in the appeal in which it dismissed the appeal.

30


 

The Company is unable to predict the final outcome of other lawsuits, including other patent infringement lawsuits, to which it is a party and therefore cannot determine the likelihood of loss nor estimate a range of possible losses. An adverse decision in any of these proceedings could significantly harm the Company's business and consolidated financial position, results of operations or cash flows.

The Company and its subsidiaries are involved in litigation matters and claims in the normal course of business. In the past, the Company and its subsidiaries have litigated to enforce their respective patents and other intellectual property rights, to enforce the terms of license agreements, to protect trade secrets, and to defend the Company’s patents against claims of invalidity. The Company expects it or its subsidiaries will be involved in similar legal proceedings in the future, including proceedings regarding infringement of its patents, and proceedings to ensure proper and full payment of royalties by licensees under the terms of its license agreements.

NOTE 15 – SEGMENT AND GEOGRAPHIC INFORMATION

The Company has one reportable segment: Intellectual Property (“IP”) Licensing. Reportable segments are identified based on the Company’s organizational structure and information reviewed by the Company’s chief operating decision maker (“CODM”) to evaluate performance and allocate resources. The Company’s Chief Executive Officer is also the CODM as defined by the authoritative guidance on segment reporting.

A portion of the Company’s revenue is derived from licensees headquartered outside of the U.S., and it is expected that this revenue will continue to account for a portion of total revenue in future periods. The table below lists the geographic revenue for the periods indicated (in thousands):

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

U.S.

 

$

68,304

 

 

 

79

%

 

$

74,495

 

 

 

74

%

 

$

208,351

 

 

 

81

%

 

$

225,560

 

 

 

75

%

Asia

 

 

12,314

 

 

 

14

 

 

 

21,434

 

 

 

21

 

 

 

32,154

 

 

 

12

 

 

 

57,416

 

 

 

19

 

Canada

 

 

3,206

 

 

 

4

 

 

 

3,244

 

 

 

3

 

 

 

9,779

 

 

 

4

 

 

 

11,487

 

 

 

4

 

Europe and Middle East

 

 

1,809

 

 

 

2

 

 

 

1,773

 

 

 

2

 

 

 

5,198

 

 

 

2

 

 

 

6,156

 

 

 

2

 

Other

 

 

468

 

 

 

1

 

 

 

451

 

 

 

 

 

 

1,374

 

 

 

1

 

 

 

1,302

 

 

 

 

 

 

$

86,101

 

 

 

100

%

 

$

101,397

 

 

 

100

%

 

$

256,856

 

 

 

100

%

 

$

301,921

 

 

 

100

%

For the three months ended September 30, 2024 and 2023, there were two and four customers, respectively, that each accounted for 10% or more of total revenue. For the nine months ended September 30, 2024 and 2023, there were two and two customers, respectively, that each accounted for 10% or more of total revenue.

The following table sets forth revenue generated from customers which comprise 10% or more of total revenue for the periods indicated:

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Customer A

 

 

20.0

%

 

 

17.0

%

 

 

20.1

%

 

 

17.1

%

Customer B

 

 

11.2

%

 

 

10.5

%

 

 

11.6

%

 

 

10.9

%

Customer C

 

*

 

 

 

10.7

%

 

*

 

 

*

 

Customer D

 

*

 

 

 

16.6

%

 

*

 

 

*

 

* denotes less than 10% of total revenue.

31


 

As of September 30, 2024, the Company had two customers representing 41% and 35% of aggregate accounts receivable, respectively. At December 31, 2023, the Company had two customers representing 42% and 28% of aggregate accounts receivable, respectively.

As of September 30, 2024 and December 31, 2023, property and equipment, net, was all located in the U.S.

NOTE 16 – SUBSEQUENT EVENTS

Declaration of Cash Dividends

On October 23, 2024, the Board declared a cash dividend of $0.05 per share of common stock, payable on December 18, 2024 to the stockholders of record at the close of business on November 27, 2024.

32


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion is intended to promote understanding of the results of operations and financial condition and should be read in conjunction with our condensed consolidated financial statements and notes thereto, and with our audited financial statements and notes thereto for the year ended December 31, 2023 found in the Form 10-K filed by us on February 23, 2023 (the “Form 10-K”). This section of this Form 10-Q generally discusses quarter over quarter comparisons of 2024 against 2023.

This quarterly report on Form 10-Q (this “Quarterly Report”) contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on information available to the Company as of the date hereof, as well as the Company’s current expectations, assumptions, estimates and projections that involve risks and uncertainties. In this context, forward-looking statements often address expected future business, financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “could,” “seek,” “see,” “will,” “may,” “would,” “might,” “potentially,” “estimate,” “continue,” “target,” similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond the Company’s control, and are not guarantees of future results. Forward-looking statements are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: the Company’s ability to implement its business strategy; the Company’s ability to enter into new and renewal license agreements with customers on favorable terms; the Company’s ability to retain and hire key personnel; uncertainty as to the long-term value of the Company’s common stock; legislative, regulatory and economic developments affecting the Company’s business; general economic and market developments and conditions; the Company’s ability to grow and expand its patent portfolios; changes in technology and development of new technology in the industries in which the Company operates; the evolving legal, regulatory and tax regimes under which the Company operates; unforeseen liabilities and expenses; risks associated with the Company’s indebtedness; the Company’s ability to achieve the intended benefits of, and its ability to recognize the tax treatment of, the spin-off of its product business; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, natural disasters and future outbreaks or pandemics, each of which may have an adverse impact on the Company’s business, results of operations, and financial condition.

Although forward-looking statements in this Quarterly Report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks, uncertainties, and changes in condition, significance, value and effect, including those discussed under the heading “Risk Factors” hereof and other documents we file from time to time with the Securities and Exchange Commission (the “SEC”), such as our annual reports on Form 10-K, our quarterly reports on Form 10-Q and our current reports on Form 8-K. Such risks, uncertainties and changes in condition, significance, value and effect could cause our actual results to differ materially from those expressed herein and in ways not readily foreseeable. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Quarterly Report and are based on information currently and reasonably known to us. We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Quarterly Report, other than as required by law. Readers are urged to carefully review and consider the various disclosures made in this Quarterly Report, which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

Business Overview

Adeia Inc. (formerly known as Xperi Holding Corporation) (“Adeia”, “we”) is a leading IP licensing platform in the consumer and entertainment space, with a diverse portfolio of media and semiconductor intellectual property and more than 11,750 patents and patent applications worldwide. In order to serve an increasingly connected world, we invent, develop, and license fundamental innovations that enhance billions of devices and shape the way millions of people explore and experience entertainment. Through our IP licensing business, we help enable extraordinary experiences at home and on the go for millions of consumers around the world, with IP that helps elevate content and improves how audiences connect with it in a way that is more intelligent, immersive and personal. Through providing the IP that helps to power smart devices, entertainment experiences and more, we have created a unified ecosystem that reaches highly-engaged consumers and uncovered new business opportunities.

33


 

On October 1, 2022, we completed the previously announced separation (“the Separation”) of its product business into an independent, publicly-traded company, Xperi Inc. (“Xperi Inc.”). The Separation was structured as a spin-off, which was achieved through Adeia’s distribution of 100 percent of the outstanding shares of Xperi Inc.’s common stock to holders of Adeia’s common stock as of the close of business on the record date of September 21, 2022 (the “Record Date”). Each Adeia stockholder of record received four shares of Xperi Inc. common stock for every ten shares of Adeia common stock that it held on the Record Date. Following the Separation, Adeia retains no ownership interest in Xperi Inc., which is now listed under the ticker symbol “XPER” on the New York Stock Exchange. Effective at the open of business on October 3, 2022, Adeia’s shares of common stock, par value $0.001 per share, began trading on the Nasdaq Global Select Market under the new ticker symbol “ADEA”.

Headquartered in Silicon Valley with more than 35 years of operating experience, we have approximately 144 employees, with substantially all of our employees located in the U.S.

Macroeconomic Conditions

Macroeconomic conditions due to inflation, geopolitical instability and global health events may have an adverse impact on our business. For example, such conditions may continue to cause volatility in the markets we serve, particularly the broad consumer electronics market. Impacts from adverse macroeconomic conditions may negatively impact our financial condition and results of operations, which could result in an impairment of our long-lived assets, including goodwill, and increased credit losses.

Reportable Segments

We operate and report in one segment: IP Licensing. We believe that this structure reflects our current operational and financial management and provides the best structure for us to focus on growth opportunities. Our Chief Executive Officer has been determined to be the Chief Operating Decision Maker (“CODM”) in consideration with the authoritative guidance on segment reporting.

We primarily license our innovations to leading companies in the broader media entertainment and semiconductor industries, and those companies developing new technologies that will help drive these industries forward. Licensing arrangements include access to one or more of our foundational patent portfolios and may also include access to some portions of our industry-leading technologies and know-how.

Financial Highlights

In evaluating our financial condition and operating performance, we primarily focus on revenue and cash flows from operations. For the three and nine months ended September 30, 2024, as compared to the same periods in 2023:

Three months ended September 30, 2024:

Revenue decreased by $15.3 million, or 15.1%, from $101.4 million in 2023 to $86.1 million in 2024.
Recurring revenues decreased by $0.9 million, or 1.1% from $83.6 million in 2023 to $82.7 million in 2024.
Non-recurring revenues decreased by $14.4 million, or 80.9% from $17.8 million in 2023 to $3.4 million in 2024.
Cash provided by operating activities decreased by $6.9 million, or 32.6% from $21.2 million in 2023 to $14.3 million in 2024.
Made $12.0 million in principal payments on our term loan, bringing the outstanding balance to $537.1 million as of September 30, 2024.

34


 

Nine months ended September 30, 2024:

Revenue decreased by $45.1 million, or 14.9%, from $301.9 million in 2023 to $256.9 million in 2024.
Recurring revenues decreased by $5.2 million, or 2.1% from $255.1 million in 2023 to $249.8 million in 2024.
Non-recurring revenues decreased by $39.8 million, or 85.0% from $46.8 million in 2023 to $7.0 million in 2024.
Cash provided by operating activities decreased by $8.3 million, or 7.3%, from $113.3 million in 2023 to $105.0 million in 2024.
Repriced our term loan which lowered our interest rate by 61 basis points and made $64.2 million in principal payments, bringing the outstanding balance to $537.1 million as of September 30, 2024.

Results of Operations

Revenue

We derive the majority of our revenue from the licensing of our intellectual property (“IP”) rights to customers. For our revenue recognition policy, including descriptions of revenue-generating activities, refer to “Note 3 – Revenue” of the Notes to Condensed Consolidated Financial Statements.

The following table presents our operating results for the periods indicated as a percentage of revenue:

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Revenue

 

 

100

%

 

 

100

%

 

 

100

%

 

 

100

%

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

17

 

 

 

14

 

 

 

17

 

 

 

13

 

Selling, general and administrative

 

 

31

 

 

 

22

 

 

 

29

 

 

 

24

 

Amortization expense

 

 

16

 

 

 

23

 

 

 

22

 

 

 

23

 

Litigation expense

 

 

3

 

 

 

2

 

 

 

4

 

 

 

2

 

Total operating expenses

 

 

67

 

 

 

61

 

 

 

72

 

 

 

62

 

Operating income

 

 

33

 

 

 

39

 

 

 

28

 

 

 

38

 

Interest expense

 

 

(15

)

 

 

(15

)

 

 

(16

)

 

 

(16

)

Other income and expense, net

 

 

2

 

 

 

2

 

 

 

2

 

 

 

2

 

Loss on debt extinguishment

 

 

 

 

 

 

 

 

 

 

 

 

Income before income taxes

 

 

20

 

 

 

26

 

 

 

14

 

 

 

24

 

Provision for (benefit from) income taxes

 

 

(3

)

 

 

2

 

 

 

2

 

 

 

5

 

Net income

 

 

23

%

 

 

24

%

 

 

12

%

 

 

19

%

 

35


 

 

The following table sets forth our revenue for the three and nine months ended September 30, 2024 and 2023 (in thousands, except for percentages):

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

Decrease

 

 

% Change

 

 

2024

 

 

2023

 

 

Decrease

 

 

% Change

 

Revenue

 

$

86,101

 

 

$

101,397

 

 

$

(15,296

)

 

 

(15

)%

 

$

256,856

 

 

$

301,921

 

 

$

(45,065

)

 

 

(15

)%

The decrease in revenue during the three months ended September 30, 2024, as compared to the same period in 2023, was primarily attributable to the execution of the long-term renewal of a license agreement with Samsung, revenue from the settlement of litigation and revenue from updated royalty audit recovery from an existing customer relating to prior periods, each of which occurred in the third quarter of 2023.

Recurring revenues decreased slightly to $82.7 million during the three months ended September 30, 2024 from $83.6 million in the same period in 2023.

Non-recurring revenues for the three months ended September 30, 2024 and 2023 were $3.4 million and $17.8 million, respectively. The decrease of $14.4 million was primarily attributable to the recognition of revenue from periods prior to the execution of the long-term renewal of a license agreement with Samsung, revenue from the settlement of litigation and revenue from updated royalty audit recovery from an existing customer relating to prior periods, each of which occurred in the third quarter of 2023.

The decrease in revenue during the nine months ended September 30, 2024, as compared to the same period in 2023, was primarily attributable to the execution of two long-term license agreements with Kioxia and Western Digital in the first quarter of 2023, recognition of revenue from periods prior to the execution of the long-term renewal of a license agreement with Samsung in the third quarter of 2023, and a decline in royalty revenue from certain Pay-TV customers, partially offset by a multi-year agreement with X Corp. for access to our media portfolio that occurred in the second quarter of 2024.

Recurring revenue for the nine months ended September 30, 2024 and 2023 were $249.8 million and $255.1 million, respectively. The decrease of $5.2 million was primarily attributable to a decrease in royalty revenue from certain Pay-TV customers.

Non-recurring revenues for the nine months ended September 30, 2024 and 2023 were $7.0 million and $46.8 million, respectively. The decrease of $39.8 million was primarily attributable to the execution of long-term license agreements with Kioxia and Western Digital in the first quarter of 2023 and revenue from periods prior to the execution of the long-term renewal of a license agreement with Samsung in the third quarter of 2023, partially offset by a settlement agreement and multi-year renewal with X Corp. for access to our media portfolio that occurred in the second quarter of 2024.

Research and Development (in thousands, except for percentages):

Research and development expense (“R&D expense”) consists primarily of personnel costs, stock-based compensation, outside engineering consulting expenses associated with new IP development, as well as costs related to patent applications and examinations, reverse engineering, materials, supplies and an allocation of facilities costs. All R&D expense is expensed as incurred. We intend to make a continued investment in our R&D efforts because we believe they are essential to grow our patent portfolios to maintain and improve our competitiveness.

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

Increase

 

 

% Change

 

 

2024

 

 

2023

 

 

Increase

 

 

% Change

 

Research and development

 

$

14,825

 

 

$

13,768

 

 

$

1,057

 

 

 

8

%

 

$

43,549

 

 

$

39,895

 

 

$

3,654

 

 

 

9

%

 

36


 

The increase in R&D expense during the three months ended September 30, 2024, as compared to the same period in 2023, was primarily due to an increase in patent prosecution, patent portfolio development costs and an increase in personnel related costs as a result of increased headcount.

The increase in R&D expense during the nine months ended September 30, 2024, as compared to the same period in 2023, was primarily due to an increase in personnel costs as a result of increased headcount and an increase in patent portfolio development costs, partially offset by a decrease in professional services costs.

Selling, General and Administrative (in thousands, except for percentages):

Selling, general and administrative (“SG&A”) expenses consist primarily of personnel costs, sales commission, advertising, branding activities, stock-based compensation, professional services, facilities costs, and expenses related to our executive finance, human resource, legal, and information technology organizations.

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

Increase

 

 

% Change

 

 

2024

 

 

2023

 

 

Increase

 

 

% Change

 

Selling, general and administrative

 

$

26,903

 

 

$

21,921

 

 

$

4,982

 

 

 

23

%

 

$

75,549

 

 

$

71,177

 

 

$

4,372

 

 

 

6

%

The increase in SG&A expense during the three months ended September 30, 2024, as compared to the same period in 2023, was primarily due to an increase in personnel related costs as a result of increased headcount and an increase in professional services costs.

The increase in SG&A expense during the nine months ended September 30, 2024, as compared to the same period in 2023, was primarily due to an increase in personnel related costs as a result of increased headcount, an increase in professional services costs, an increase in certain administrative costs associated with the repricing of our credit facility in the second quarter of 2024, partially offset by decreases in separation costs that were incurred in 2023 but did not recur in 2024, lower insurance costs and recovery of certain bad debt expenses.

Amortization Expense (in thousands, except for percentages):

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

Decrease

 

 

% Change

 

 

2024

 

 

2023

 

 

Decrease

 

 

% Change

 

Amortization expense

 

$

13,600

 

 

$

23,386

 

 

$

(9,786

)

 

 

(42

)%

 

$

56,787

 

 

$

70,725

 

 

$

(13,938

)

 

 

(20

)%

The decrease in amortization expense during the three and nine months ended September 30, 2024, as compared to the same periods in 2023, was primarily due to certain intangible assets becoming fully amortized during 2024. The decrease was partially offset by an increase in amortization expense as a result of patents acquired in 2024.

Litigation Expense (in thousands, except for percentages):

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

Increase

 

 

% Change

 

 

2024

 

 

2023

 

 

Increase

 

 

% Change

 

Litigation expense

 

$

2,652

 

 

$

2,205

 

 

$

447

 

 

 

20

%

 

$

9,844

 

 

$

7,161

 

 

$

2,683

 

 

 

37

%

The increase in litigation expense during the three and nine months ended September 30, 2024, as compared to the same periods in 2023, was primarily due to increased activity in current litigation matters.

37


 

We expect that litigation expense will continue to be a significant portion of our operating expenses, as it is used to enforce and protect our IP and contract rights. Litigation expense may fluctuate between periods because of planned or ongoing litigation, as described in Part II, Item 1 – Legal Proceedings.

Interest Expense (in thousands, except for percentages):

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

Decrease

 

 

% Change

 

 

2024

 

 

2023

 

 

Decrease

 

 

% Change

 

Interest expense

 

$

12,758

 

 

$

15,659

 

 

$

(2,901

)

 

 

(19

)%

 

$

40,229

 

 

$

47,137

 

 

$

(6,908

)

 

 

(15

)%

The decrease in interest expense during the three and nine months ended September 30, 2024, as compared to the same periods in 2023, was primarily due to lower debt balance and lower interest rates on our variable interest rate debt due to the repricing of our Term Loan B during the second quarter of 2024.

We anticipate interest expense will continue to decrease in 2024, when compared to 2023, as a result of a full year of a lower debt balance, the reduction of the interest rate margin benefited from the repricing of our Term Loan B during the second quarter of 2024, and the Federal Reserve interest rate cut during the third quarter of 2024.

Other Income and Expense, Net (in thousands, except for percentages):

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

Decrease

 

 

% Change

 

 

2024

 

 

2023

 

 

Decrease

 

 

% Change

 

Other income and expense, net

 

$

1,431

 

 

$

1,486

 

 

$

(55

)

 

 

(4

)%

 

$

4,259

 

 

$

4,723

 

 

$

(464

)

 

 

(10

)%

The decrease in other income and expense, net during the three and nine months ended September 30, 2024, as compared to the same periods in 2023, was primarily due to a decrease in interest income from significant financing components from certain revenue contracts.

Loss on Debt Extinguishment

During the nine months ended September 30, 2024, we recognized $0.5 million associated with the repricing of our Term Loan B and there were no such costs in 2023. Refer to discussion below for further detail on the repricing of our Term Loan B.

Provision for Income Taxes

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

Decrease

 

 

% Change

 

 

2024

 

 

2023

 

 

Decrease

 

 

% Change

 

Provision for (benefit from) income taxes

 

$

(2,520

)

 

$

1,712

 

 

$

(4,232

)

 

 

(247

)%

 

$

6,109

 

 

$

15,877

 

 

$

(9,768

)

 

 

(62

)%

 

38


 

Our income tax provision for interim periods is based on the estimated annual effective tax rate adjusted for discrete items during the period. For the three months ended September 30, 2024, we recorded income tax benefit of $2.5 million on pretax income of $16.8 million, and for the nine months ended September 30, 2024, we recorded an income tax expense of $6.1 million on pretax income of $34.7 million, which resulted in effective tax rates of (14.9)% and 17.6%, respectively, for the three and nine months ended September 30, 2024. The decrease in income tax expense for the three months ended September 30, 2024, as compared to the same period in the prior year was primarily due to certain unrealized foreign exchange benefits associated with South Korea withholding tax refund claims. The decrease in income tax expense for the nine months ended September 30, 2024, as compared to the same period in the prior year was primarily due to certain unrealized foreign exchange benefits associated with South Korea withholding tax refund claims.

For the three months ended September 30, 2023, we recorded an income tax expense of $1.7 million on pretax income of $25.9 million, and for nine months ended September 30, 2023, we recorded an income tax expense of $15.9 million on pretax income of $70.5 million, which resulted in effective tax rates of 6.6% and 22.5%, respectively, for the three and nine months ended September 30, 2023.

The effective tax rate varies from the 21% U.S. federal tax rate primarily due to unrealized foreign exchange gain or loss on prior year South Korea withholding tax refund claims.

We periodically evaluate the realizability of our net deferred tax assets based on all available evidence, both positive and negative. After considering the evidence to assess the recoverability of our net deferred tax assets, we concluded that it was more-likely-than-not that we would realize our federal and certain state deferred tax assets.

Liquidity and Capital Resources

The following table presents selected financial information related to our liquidity and significant sources and uses of cash and cash equivalents for the nine months ended September 30, 2024 and 2023.

 

 

 

As of

 

(in thousands)

 

September 30, 2024

 

 

December 31, 2023

 

Cash and cash equivalents

 

$

60,698

 

 

$

54,560

 

Marketable securities

 

 

28,486

 

 

 

29,012

 

Total cash, cash equivalents and marketable securities

 

$

89,184

 

 

$

83,572

 

 

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

Net cash from operating activities

 

$

105,001

 

 

$

113,315

 

Net cash from investing activities

 

$

(8,394

)

 

$

(31,829

)

Net cash from financing activities

 

$

(90,469

)

 

$

(144,186

)

Our primary sources of liquidity and capital resources are our operating cash flows and our short-term investments in marketable securities. Cash, cash equivalents and marketable securities were $89.2 million at September 30, 2024, an increase of $5.6 million from $83.6 million at December 31, 2023. This increase primarily resulted from $105.0 million of cash generated from operations, and $1.5 million in proceeds from purchases through our employee stock purchase program and exercise of stock options, partially offset by $64.2 million in repayment of our long-term debt, $11.6 million in repurchases of common stock associated with tax withholdings on equity awards, $16.3 million in dividends paid, $1.3 million in purchases of property and equipment, and $8.5 million in purchases of intangible assets.

39


 

The primary objectives of our investment activities are to preserve principal and to maintain liquidity, while at the same time capturing a market rate of return. To achieve these objectives, we maintain a diversified portfolio of securities including money market funds and debt securities such as corporate bonds and notes, municipal bonds and notes, commercial paper, treasury and agency notes and bills and certificates of deposit. Our marketable debt securities are classified as available-for-sale (“AFS”) with credit losses recognized as a credit loss expense and non-credit related unrealized gains and losses, net of tax, recorded in accumulated other comprehensive income or loss.

For information about our material cash requirements, see “Liquidity and Capital Resources” in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2023. Other than the principal payments of $64.2 million made by us under the existing Term Loan B during the nine months ended September 30, 2024, our cash requirements have not materially changed since December 31, 2023.

We expect to continue to make additional payments on our existing debt from cash generated from operations. In addition to the cash requirements outlined above, we have returned cash to stockholders through both quarterly dividend payments and repurchases of our common stock under our stock repurchase plan.

Quarterly Dividends

In September 2024, we paid quarterly cash dividends of $0.05 per share of common stock. In October 2024, our board of directors (the “Board”) authorized payment of a quarterly cash dividend of $0.05 per share, to be paid in December 2024.

 

Stock Repurchase Plan

On June 12, 2020, our Board terminated a prior stock repurchase program and approved a new stock repurchase plan (the “Plan”), which provides for the repurchase of up to $150.0 million of our common stock dependent on market conditions, share price and other factors. No expiration has been specified for this Plan. On April 22, 2021, our Board authorized an additional $100.0 million of purchases under the Plan. The stock repurchases may be made from time to time, through solicited or unsolicited transactions in the open market, in privately negotiated transactions, or pursuant to a Rule 10b5-1 plan. Since the inception of the Plan, and through September 30, 2024, we have repurchased an aggregate of approximately 10.0 million shares of common stock at a total cost of $172.2 million at an average price of $17.24. As of September 30, 2024, the total remaining amount available for repurchase under the Plan was $77.8 million. We may continue to execute authorized repurchases from time to time under the Plan. The amount and timing of any repurchases under the Plan depend on a number of factors, including, but not limited to, the trading price, volume and availability of our common shares. There is no guarantee that such repurchases under the Plan will enhance the value of our common stock.

We believe that based on current levels of operations and anticipated growth, our cash from operations, together with cash and cash equivalents currently available, will be sufficient to satisfy our currently anticipated cash requirements through at least the next 12 months and thereafter for the foreseeable future. Poor financial results, unanticipated expenses, unanticipated acquisitions of technologies or businesses, or unanticipated strategic investments could give rise to additional financing requirements sooner than we expect. There can be no assurance that equity or debt financing will be available when needed or, if available, that such financing will be on terms satisfactory to us. The sale of additional equity securities could result in dilution to our stockholders. The incurrence of indebtedness could result in increased debt service obligations and may include covenants that would restrict our operations.

Cash Flows from Operating Activities

Cash flows provided by operations were $105.0 million for the nine months ended September 30, 2024, were primarily due to our net income of $28.6 million being adjusted for non-cash items of amortization of intangible assets of $56.8 million, amortization of debt issuance costs of $2.4 million, stock-based compensation expense of $19.2 million, depreciation of property and equipment of $1.5 million and $(0.7) million in changes in operating assets and liabilities including payment during the period of employee bonuses earned in 2023.

40


 

Cash flows provided by operations were $113.3 million for the nine months ended September 30, 2023, primarily due to our net income of $54.7 million being adjusted for non-cash items of amortization of intangible assets of $70.7 million, amortization of debt issuance costs of $3.3 million and stock-based compensation expense of $13.1 million. These increases were partially offset by $29.6 million in changes in operating assets and liabilities including payment during the period of employee bonuses earned in 2022.

Cash Flows from Investing Activities

Net cash used in investing activities was $8.4 million for the nine months ended September 30, 2024, primarily related to purchases of short-term investments of $25.1 million, purchases of property and equipment of $1.3 million, purchases of intangible assets of $8.5 million, and proceeds from maturities of investments of $26.5 million.

Net cash used in investing activities was $31.8 million for the nine months ended September 30, 2023, primarily related to purchases of short-term investments of $33.6 million, capital expenditures of $1.9 million and proceeds from maturities of investments of $3.8 million.

Capital Expenditures

Our capital expenditures for property and equipment consist primarily of leasehold improvements, purchases of computer hardware and software, information systems, and semiconductor production and test equipment. During the nine months ended September 30, 2024 and 2023, we spent $1.3 million and $1.9 million on capital expenditures, respectively, and we expect capital expenditures in the remainder of 2024 to be approximately $1.0 million. Our capital expenditures for intangible assets consists primarily of acquired patents. During the nine months ended September 30, 2024, we spent $8.5 million on purchases of intangible assets. These expenditures are expected to be financed with cash from operations, existing cash and cash equivalents and short-term investments. There can be no assurance that current expectations will be realized, and plans are subject to change upon further review of our capital expenditure needs.

Cash Flows from Financing Activities

Net cash used in financing activities was $90.5 million for the nine months ended September 30, 2024 due to $64.2 million in repayment of indebtedness, $16.3 million in dividends paid, $11.6 million in repurchases of common stock for tax withholdings on equity awards, partially offset by $1.5 million in proceeds from purchases through our employee stock purchase program and exercise of stock options.

Net cash used in financing activities was $144.2 million for the nine months ended September 30, 2023 due to $118.9 million in repayment of indebtedness, $16.0 million in dividends paid, $10.5 million in repurchases of common stock for tax withholdings on equity awards, partially offset by $1.1 million in proceeds from the issuance of common stock under our employee stock grant programs and employee stock purchase plans.

 

Long-term Debt

On June 8, 2021, we entered into Amendment No. 1 (“Amendment No. 1”) to that certain Credit Agreement dated June 1, 2020 by and among us, the lenders party thereto and Bank of America, N.A., as administrative agent and collateral agent (the “2020 Credit Agreement”). The 2020 Credit Agreement initially provided for a five-year senior secured term loan B facility in an aggregate principal amount of $1,050 million (the “2020 Term Loan B Facility”). Amendment No. 1 provided for, among other things, (i) a new tranche of term loans (the “2021 Refinanced Term Loan B”) in an aggregate principal amount of $810.0 million, (ii) a reduction of the interest rate margin applicable to such loans to (x) in the case of base rate loans, 2.50% per annum and (y) in the case of Eurodollar loans, LIBOR plus a margin of 3.50% per annum, (iii) a prepayment premium of 1.00% in connection with any repricing transaction with respect to the 2021 Refinanced Term Loan B within six months of the closing date of Amendment No. 1, (iv) an extension of the maturity to June 8, 2028, and (v) certain additional amendments, including amendments to provide us with additional flexibility under the covenant governing restricted payments.

41


 

On May 30, 2023, we entered into Amendment No. 3 (“Amendment No. 2”) to the 2020 Credit Agreement to replace the reference to LIBOR as the base rate with the reference to the Secured Overnight Financing Rate “SOFR” as administered by the Federal Reserve Bank of New York.

On May 20, 2024, we entered into Amendment No. 3 (“Amendment No. 3”) to the 2020 Credit Agreement, which provided for, among other things, (i) a repricing of the 2020 Term Loan B Facility through a refinancing of the entire amount of the 2021 Refinanced Term Loan B with a new tranche of term loans (the “2024 Term Loan B”) in an aggregate principal amount of $561.1 million, (ii) a reduction of the interest rate margin applicable to such loans to (x) in the case of SOFR loans, SOFR plus a margin of 3.00% per annum and (y) in the case of base rate loans, 2.00% per annum, (iii) a reduction in the excess cash flow mandatory payment thresholds and (iv) a prepayment premium of 1.00% in connection with any repricing transaction with respect to the 2024 Term Loan B within six months of the closing date of Amendment No. 3. The 2024 Term Loan B will mature on June 8, 2028, the same date upon which the 2021 Refinanced Term Loan B matured prior to giving effect to Amendment No. 3.

At September 30, 2024, $537.1 million was outstanding under the term loan B facility with an interest rate, including unamortized debt discount and issuance costs of $12.7 million. Interest is payable monthly. Under the existing loan agreement, we have future minimum principal payments for our debt of $7.0 million in the remainder of 2024, $28.1 million each year from 2025 through 2027, with the remaining principal balance of $445.9 million due in 2028. After the Separation, we own the debt under the term loan B facility. Additionally, we paid $29.1 million during the nine months ended September 30, 2024, based on certain leverage ratios and our excess cash flow generated for the year ended December 31, 2023. We are obligated to continue to pay a portion of excess cash flows on an annual basis. The term loan B facility contains customary covenants, and as of September 30, 2024, we were in full compliance with such covenants. The 2020 Credit Agreement, as amended, also requires that we continue to make cash payments on an annual basis based on certain leverage ratios and excess cash flow generated for the immediately preceding fiscal year. The cash payments are applied to the remaining principal balance due at final maturity.

Critical Accounting Policies and Estimates

During the three and nine months ended September 30, 2024, there were no significant changes in our critical accounting policies and estimates. See “Note 2 – Summary of Significant Accounting Policies” of Notes to Condensed Consolidated Financial Statements for additional detail. For a discussion of our critical accounting policies and estimates, see Part II, Item 7 – Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K.

Recent Accounting Pronouncements

See “Note 2 – Summary of Significant Accounting Policies” of the Notes to Condensed Consolidated Financial Statements for a full description of recent accounting pronouncements including the respective expected dates of adoption.

42


 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

For a discussion of our market risk, see Part II, Item 7A – Quantitative and Qualitative Disclosures About Market Risk in our Annual Report on Form 10-K.

Item 4. Controls and Procedures

Attached as exhibits to this Form 10-Q are certifications of Adeia Inc.’s Chief Executive Officer and Chief Financial Officer, which are required in accordance with Rule 13a-14 of the Exchange Act. This “Controls and Procedures” section includes information concerning the controls and controls evaluation referred to in the certifications and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.

Evaluation of Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted pursuant to the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this report (the evaluation date). Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded as of the evaluation date that our disclosure controls and procedures were effective to provide reasonable assurance that the information relating to Adeia Inc., including our consolidated subsidiaries, required to be disclosed in our SEC reports (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) is accumulated and communicated to Adeia Inc.’s management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act, during the last fiscal quarter covered by this Quarterly Report on Form 10-Q that materially affected or are reasonably likely to materially affect our internal control over financial reporting.

43


 

PART II - OTHER INFORMATION

In the normal course of our business, we are involved in legal proceedings. In the past, we have litigated to enforce our patents and other intellectual property rights (“IP”), to enforce the terms of license agreements, to protect trade secrets and to defend our patents against claims of invalidity. We expect to continue to be involved in similar legal proceedings in the future, including proceedings regarding infringement of our patents and proceedings to ensure proper and full payment of royalties by licensees under the terms of our license agreements.

We cannot predict the outcome of any of the proceedings described below, other than to the extent such proceedings have concluded. An adverse decision in any of these proceedings could significantly harm our business and our consolidated financial position, results of operations, and cash flows.

Patent Infringement Litigation

In the ordinary course of our business, we engage in litigation to protect our IP from infringement. While litigation is never our preference, and we prefer to reach mutually agreeable commercial licensing arrangements with third parties, it is sometimes a necessary step to effectively protect our investment in our IP. As a result of these lawsuits, defendants have often filed Inter Partes Review (“IPR”) petitions with the U.S. Patent Office’s Patent Trial and Appeal Board (and other similar post-grant proceedings outside of the U.S.) seeking to invalidate one or more of our patents. We are currently engaged in multiple lawsuits with several third parties.

Videotron Patent Infringement Litigation

On June 23, 2017, Adeia Guides Inc. (formerly known as Rovi Guides, Inc.) and Adeia Media Solutions Inc. (formerly known as TiVo Solutions Inc.) (together, “Adeia Media”) filed a patent infringement complaint against Videotron Ltd. and Videotron G.P. (together, “Videotron”) in Toronto, Canada, alleging infringement of six patents (“Videotron 1”). On June 10, 2022, the Federal Court of Canada issued its decision in the case finding in favor of Videotron and its legacy “illico” platform. Specifically, the Court found invalid each of the asserted claims related to the four remaining patents involved in the case. In Canada, the prevailing party in patent litigation is entitled to reimbursement of certain of its costs and expenses. Accordingly, we paid $2.5 million for expense reimbursement in the fourth quarter of 2022. On September 12, 2022, Adeia Media filed a notice of appeal with the Federal Court of Appeal of Canada appealing the decision of the Federal Court of Canada. On January 30, 2023, Adeia Media filed its opening memorandum of fact and law. Videotron filed its memorandum of fact and law on April 17, 2023. On November 28, 2023, the Federal Court of Appeal of Canada held a hearing on the appeal and took the matter under reserve. On August 6, 2024, the Federal Court of Appeal of Canada issued a judgment in the appeal in which it dismissed the appeal.

On May 21, 2021, Adeia Media filed a patent infringement complaint against Videotron in Toronto, Canada, alleging infringement of four patents (“Videotron 2”). On July 21, 2021, the Federal Court of Canada held a case management conference in Videotron 2, shortly before which Videotron filed a motion to strike various portions of the statement of claim. On March 22, 2022, the Court issued an order on Videotron’s motion to strike, dismissing the motion in its entirety. On April 1, 2022, Videotron filed an appeal of the Court’s order dismissing Videotron’s motion to strike. On June 30, 2022, the Court of Appeal issued its decision in Videotron’s appeal in which it ruled in Adeia Media’s favor and dismissed Videotron’s appeal. The trial is scheduled to start on January 20, 2025.

Bell and Telus Patent Infringement Litigation

On January 19, 2018, Adeia Media filed a patent infringement complaint against Bell Canada (and four of its affiliates) (collectively, “Bell”) in Toronto, Canada, alleging infringement of six patents (“Bell 1”). On February 2, 2018, Adeia Media filed a patent infringement complaint against Telus Corporation (and two of its affiliates) (collectively, “Telus”) in Toronto, Canada, alleging infringement of the same six patents (“Telus 1”). Bell 1 and Telus 1 were heard together for purposes of pre-trial and trial proceedings. On October 7, 2022, the Federal Court of Canada issued its decision in the two cases finding in favor of Bell and Telus and their respective IPTV services,

44


 

Bell Fibe TV and Telus Optik TV. Specifically, the Court found invalid each of the asserted claims of the four remaining patents involved in the case. In Canada, the prevailing party in patent litigation is entitled to reimbursement of certain of its costs and expenses. Accordingly, we paid $2.8 million for expense reimbursement in the second quarter of 2023. On November 7, 2022, Adeia Media filed a notice of appeal with the Federal Court of Appeal of Canada appealing the decision of the Federal Court of Canada. On June 2, 2023, Adeia Media filed its opening memorandum of fact and law. Bell and Telus filed a combined memorandum of fact and law on August 18, 2023. On November 29, 2023, the Federal Court of Appeal of Canada held a hearing on the appeal and took the matter under reserve. On August 6, 2024, the Federal Court of Appeal of Canada issued a judgment in the appeal in which it dismissed the appeal.

On July 27, 2021, Adeia Media filed a patent infringement complaint against Bell Canada and four of its affiliates, Telefonaktiebolaget L M Ericsson, Ericsson Canada Inc., and MK Systems USA Inc. and MK Mediatech Canada Inc. (collectively, “Defendants”) in Toronto, Canada, alleging infringement of four patents (“Bell 2”). The Defendants filed a motion to strike various portions of the statement of claim in Bell 2. On March 22, 2022, the Court issued an order on Defendants’ motion to strike, dismissing-in-part and granting-in-part. On April 1, 2022, the Defendants filed a Notice of Motion to Appeal the Court’s order on Defendants’ motion to strike. On June 30, 2022, the Court of Appeal issued its decision in Defendants' appeal in which it ruled in Adeia Media's favor and dismissed Defendants’ appeal. On September 30, 2022, Defendants filed a motion for bifurcation, asking the Federal Court of Canada to bifurcate the case into two phases: a first phase related to liability and injunction and second phase addressing damages if liability is found. The Court held a hearing on the motion for bifurcation on December 12, 2022. On February 15, 2023, the Court issued an order granting the motion for bifurcation in which the Court bifurcated the liability and injunction phase from the damages quantification phase of the case. Discovery in the case began in November 2022. The trial is scheduled to start on April 28, 2025.

Shaw Breach of Contract Litigation

On October 2, 2023, Adeia Guides Inc., Adeia Media Solutions Inc., and Adeia Media Holdings LLC (collectively, “Adeia Media”) filed a complaint against Shaw Cablesystems G.P. and Shaw Satellite G.P. (together “Shaw”) in the United States District Court for the Southern District of New York, alleging breach of contract by Shaw for failure to pay royalties owed to Adeia Media under the license agreement between the parties. On October 8, 2024, Shaw filed a motion to dismiss the complaint. On October 29, 2024, Adeia filed its response. Shaw’s motion to dismiss reply brief is due on November 12, 2024. The trial date has not been set.

Disney Patent Infringement Litigation

On November 7, 2024, Adeia Technologies, Inc., Adeia Guides Inc., and Adeia Media Holdings LLC filed a complaint against The Walt Disney Company, Disney Media and Entertainment Distribution LLC, Disney DTC LLC, Disney Streaming Services LLC, Disney Entertainment & Sports LLC, Disney Platform Distribution, Inc., BAMTech, LLC, Hulu, LLC, and ESPN, Inc. in the United States District Court for the District of Delaware, alleging infringement of six patents.

On November 7, 2024, Adeia Solutions LLC (“Adeia Solutions”) filed a complaint against The Walt Disney Company Benelux (BV), Disney Interactive Studios, Inc., and The Walt Disney Company Limited (collectively, “Disney Europe Defendants”) in the Regional Court of Munich, Germany, alleging infringement of one patent.

On November 7, 2024, Adeia Guides Inc. (“Adeia Guides”) filed a complaint against the Disney Europe Defendants in the Unified Patent Court (“UPC”) Munich Local Division, Germany, alleging infringement of one patent.

On November 7, 2024, Adeia Guides filed a complaint against the Disney Europe Defendants in the UPC The Hague Local Division, The Netherlands, alleging infringement of one patent.

On November 11, 2024, Adeia Guides filed a complaint against The Walt Disney Company (Brasil) LTDA in Rio de Janeiro State Court, Brazil, alleging infringement of four patents.

No case schedule has been set yet.

45


 

Item 1A. Risk Factors

There were no material changes to the risk factors previously disclosed in Part 1, Item 1A. of our Annual Report on Form 10-K for the year ended December 31, 2023, which is incorporated by reference herein.

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities

Not applicable.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

During the three and nine months ended September 30, 2024, there were no Rule 10b5-1 plans or non-Rule 10b5-1 trading arrangements adopted, modified or terminated by any director or officer of the Company.

46


 

Item 6. Exhibits

 

Exhibit

Number

 

Exhibit Title

 

 

 

4.1

 

The Registrant’s Amended and Restated 2020 Equity Incentive Plan (filed as Exhibit 4.4 to the Registrant’s Registration Statement on Form S-8 filed with the SEC on May 9, 2024, and incorporated herein by reference)

 

 

 

10.1

 

Amendment No. 3 to Credit Agreement, dated as of May 20, 2024, among Adeia Inc., the subsidiaries of Adeia Inc. party thereto, Bank of America, N.A., as administrative agent and collateral agent, and the lenders party thereto (including Conformed Credit Agreement giving effect to Amendments) (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on May 20, 2024, and incorporated herein by reference)

 

 

 

31.1

 

Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

 

 

 

31.2

 

Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

 

 

 

32.1

 

Certification of the Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

101.INS

 

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

 

 

 

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

 

 

 

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document

 

 

 

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

104

 

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 

47


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: November 12, 2024

 

ADEIA INC.

 

 

By:

 

/s/ Keith A. Jones

 

 

Keith A. Jones

Chief Financial Officer

 

48